{"status": "ok", "message-type": "work-list", "message-version": "1.0.0", "message": {"facets": {}, "total-results": 779301, "items": [{"indexed": {"date-parts": [[2019, 11, 26]], "date-time": "2019-11-26T01:55:01Z", "timestamp": 1574733301909}, "reference-count": 0, "publisher": "American Society for Microbiology", "issue": "4", "content-domain": {"domain": ["asm.org"], "crossmark-restriction": true}, "short-container-title": ["Mol. Cell. Biol."], "published-print": {"date-parts": [[1992, 4]]}, "abstract": "<jats:p>The translocation (6;9) is associated with a specific subtype of acute myeloid leukemia (AML). Previously, it was found that breakpoints on chromosome 9 are clustered in one of the introns of a large gene named Cain (can). cDNA probes derived from the 3' part of can detect an aberrant, leukemia-specific 5.5-kb transcript in bone marrow cells from t(6;9) AML patients. cDNA cloning of this mRNA revealed that it is a fusion of sequences encoded on chromosome 6 and 3' can. A novel gene on chromosome 6 which was named dek was isolated. In dek the t(6;9) breakpoints also occur in one intron. As a result the dek-can fusion gene, present in t(6;9) AML, encodes an invariable dek-can transcript. Sequence analysis of the dek-can cDNA showed that dek and can are merged without disruption of the original open reading frames and therefore the fusion mRNA encodes a chimeric DEK-CAN protein of 165 kDa. The predicted DEK and CAN proteins have molecular masses of 43 and 220 kDa, respectively. Sequence comparison with the EMBL data base failed to show consistent homology with any known protein sequences.</jats:p>", "DOI": "10.1128/mcb.12.4.1687", "type": "journal-article", "created": {"date-parts": [[2015, 10, 6]], "date-time": "2015-10-06T00:29:18Z", "timestamp": 1444091358000}, "page": "1687-1697", "update-policy": "http://dx.doi.org/10.1128/asmj-crossmark-policy-page", "source": "Crossref", "is-referenced-by-count": 229, "title": ["The translocation (6;9), associated with a specific subtype of acute myeloid leukemia, results in the fusion of two genes, dek and can, and the expression of a chimeric, leukemia-specific dek-can mRNA."], "prefix": "10.1128", "volume": "12", "author": [{"given": "M", "family": "von Lindern", "sequence": "first", "affiliation": []}, {"given": "M", "family": "Fornerod", "sequence": "additional", "affiliation": []}, {"given": "S", "family": "van Baal", "sequence": "additional", "affiliation": []}, {"given": "M", "family": "Jaegle", "sequence": "additional", "affiliation": []}, {"given": "T", "family": "de Wit", "sequence": "additional", "affiliation": []}, {"given": "A", "family": "Buijs", "sequence": "additional", "affiliation": []}, {"given": "G", "family": "Grosveld", "sequence": "additional", "affiliation": []}], "member": "235", "published-online": {"date-parts": [[1992, 4, 1]]}, "container-title": ["Molecular and Cellular Biology"], "language": "en", "link": [{"URL": "https://syndication.highwire.org/content/doi/10.1128/MCB.12.4.1687", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2016, 12, 23]], "date-time": "2016-12-23T17:44:14Z", "timestamp": 1482515054000}, "score": 117.07622, "issued": {"date-parts": [[1992, 4]]}, "references-count": 0, "journal-issue": {"published-online": {"date-parts": [[1992, 4, 1]]}, "published-print": {"date-parts": [[1992, 4]]}, "issue": "4"}, "alternative-id": ["10.1128/MCB.12.4.1687"], "URL": "http://dx.doi.org/10.1128/mcb.12.4.1687", "ISSN": ["0270-7306", "1098-5549"], "issn-type": [{"value": "0270-7306", "type": "print"}, {"value": "1098-5549", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 20]], "date-time": "2019-11-20T18:26:25Z", "timestamp": 1574274385991}, "reference-count": 37, "publisher": "Wiley", "issue": "3", "license": [{"URL": "http://doi.wiley.com/10.1002/tdm_license_1.1", "start": {"date-parts": [[2015, 9, 1]], "date-time": "2015-09-01T00:00:00Z", "timestamp": 1441065600000}, "delay-in-days": 8370, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Genes Chromosom. Cancer"], "published-print": {"date-parts": [[1992, 10]]}, "DOI": "10.1002/gcc.2870050309", "type": "journal-article", "created": {"date-parts": [[2007, 2, 21]], "date-time": "2007-02-21T23:09:24Z", "timestamp": 1172099364000}, "page": "227-234", "source": "Crossref", "is-referenced-by-count": 63, "title": ["Characterization of the translocation breakpoint sequences of twoDEK-CAN fusion genes present in t(6;9) acute myeloid leukemia and aSET-CAN fusion gene found in a case of acute undifferentiated leukemia"], "prefix": "10.1002", "volume": "5", "author": [{"given": "Marieke", "family": "Von Lindern", "sequence": "first", "affiliation": []}, {"given": "Dimitri", "family": "Breems", "sequence": "additional", "affiliation": []}, {"given": "Sjoz\u00e8f", "family": "Van Baal", "sequence": "additional", "affiliation": []}, {"given": "Henk", "family": "Adriaansen", "sequence": "additional", "affiliation": []}, {"given": "Gerard", "family": "Grosveld", "sequence": "additional", "affiliation": []}], "member": "311", "reference": [{"key": "10.1002/gcc.2870050309-BIB1", "author": "Adriaansen", "volume": "2", "first-page": "136", "year": "1988", "journal-title": "Leukemia"}, {"key": "10.1002/gcc.2870050309-BIB2", "author": "Adriaansen", "volume": "4", "first-page": "404", "year": "1990", "journal-title": "Leukemia"}, {"key": "10.1002/gcc.2870050309-BIB3", "author": "Adriaansen", "volume": "5", "first-page": "744", "year": "1991", "journal-title": "Leukemia"}, {"key": "10.1002/gcc.2870050309-BIB4", "author": "Alt", "volume": "79", "first-page": "4118", "year": "1982", "journal-title": "Proc Natl Acad Sci USA", "DOI": "10.1073/pnas.79.13.4118", "doi-asserted-by": "crossref"}, {"key": "10.1002/gcc.2870050309-BIB5", "author": "Begley", "volume": "86", "first-page": "2031", "year": "1989", "journal-title": "Proc Natl Acad Sci USA", "DOI": "10.1073/pnas.86.6.2031", "doi-asserted-by": "crossref"}, {"key": "10.1002/gcc.2870050309-BIB6", "author": "Boehm", "volume": "3", "first-page": "2344", "year": "1989", "journal-title": "FASEB J", "DOI": "10.1096/fasebj.3.12.2676678", "doi-asserted-by": "crossref"}, {"key": "10.1002/gcc.2870050309-BIB7", "author": "Boehm", "volume": "8", "first-page": "2621", "year": "1989", "journal-title": "EMBO J", "DOI": "10.1002/j.1460-2075.1989.tb08402.x", "doi-asserted-by": "crossref"}, {"key": "10.1002/gcc.2870050309-BIB8", "author": "Brown", "volume": "9", "first-page": "3343", "year": "1990", "journal-title": "EMBO J", "DOI": "10.1002/j.1460-2075.1990.tb07535.x", "doi-asserted-by": "crossref"}, {"key": "10.1002/gcc.2870050309-BIB9", "author": "Chen", "volume": "9", "first-page": "415", "year": "1990", "journal-title": "EMBO J", "DOI": "10.1002/j.1460-2075.1990.tb08126.x", "doi-asserted-by": "crossref"}, {"key": "10.1002/gcc.2870050309-BIB10", "author": "Chen", "volume": "2", "first-page": "261", "year": "1988", "journal-title": "Leukemia"}, {"key": "10.1002/gcc.2870050309-BIB11", "author": "Chen", "volume": "4", "first-page": "195", "year": "1989", "journal-title": "Oncogene"}, {"key": "10.1002/gcc.2870050309-BIB12", "author": "Ceary", "volume": "66", "first-page": "619", "year": "1991", "journal-title": "Cell", "DOI": "10.1016/0092-8674(91)90105-8", "doi-asserted-by": "crossref"}, {"key": "10.1002/gcc.2870050309-BIB13", "author": "Croce", "volume": "49", "first-page": "155", "year": "1987", "journal-title": "Cell", "DOI": "10.1016/0092-8674(87)90552-6", "doi-asserted-by": "crossref"}, {"key": "10.1002/gcc.2870050309-BIB14", "author": "Cuneo", "volume": "42", "first-page": "209", "year": "1989", "journal-title": "Cancer Genet Cytogenet", "DOI": "10.1016/0165-4608(89)90089-7", "doi-asserted-by": "crossref"}, {"key": "10.1002/gcc.2870050309-BIB15", "author": "De Klein", "volume": "14", "first-page": "7071", "year": "1986", "journal-title": "Nucleic Acids Res", "DOI": "10.1093/nar/14.17.7071", "doi-asserted-by": "crossref"}, {"key": "10.1002/gcc.2870050309-BIB16", "author": "Fanning", "volume": "910", "first-page": "203", "year": "1987", "journal-title": "Biochim Biophys Acta", "DOI": "10.1016/0167-4781(87)90112-6", "doi-asserted-by": "crossref"}, {"key": "10.1002/gcc.2870050309-BIB17", "author": "Finger", "volume": "234", "first-page": "982", "year": "1986", "journal-title": "Science", "DOI": "10.1126/science.3490692", "doi-asserted-by": "crossref"}, {"key": "10.1002/gcc.2870050309-BIB18", "author": "Finger", "volume": "86", "first-page": "5039", "year": "1989", "journal-title": "Proc Natl Acad Sci USA", "DOI": "10.1073/pnas.86.13.5039", "doi-asserted-by": "crossref"}, {"key": "10.1002/gcc.2870050309-BIB19", "author": "Hsieh", "volume": "4", "first-page": "1951", "year": "1990", "journal-title": "Genes Dev", "DOI": "10.1101/gad.4.11.1951", "doi-asserted-by": "crossref"}, {"key": "10.1002/gcc.2870050309-BIB20", "author": "Kiyama", "volume": "88", "first-page": "10450", "year": "1991", "journal-title": "Proc Natl Acad Sci USA", "DOI": "10.1073/pnas.88.23.10450", "doi-asserted-by": "crossref"}, {"key": "10.1002/gcc.2870050309-BIB21", "author": "Krowczynska", "volume": "18", "first-page": "1121", "year": "1990", "journal-title": "Nuclei. Acids Res", "DOI": "10.1093/nar/18.5.1121", "doi-asserted-by": "crossref"}, {"key": "10.1002/gcc.2870050309-BIB22", "author": "Landau", "volume": "7", "first-page": "3237", "year": "1987", "journal-title": "Mol Cell Biol", "DOI": "10.1128/MCB.7.9.3237", "doi-asserted-by": "crossref"}, {"key": "10.1002/gcc.2870050309-BIB23", "author": "Papadopoulos", "volume": "1", "first-page": "233", "year": "1990", "journal-title": "Genes Chrom Cancer", "DOI": "10.1002/gcc.2870010308", "doi-asserted-by": "crossref"}, {"key": "10.1002/gcc.2870050309-BIB24", "author": "Pear", "volume": "2", "first-page": "499", "year": "1988", "journal-title": "Oncogene"}, {"key": "10.1002/gcc.2870050309-BIB25", "author": "Rabbitts", "volume": "3", "first-page": "99", "year": "1988", "journal-title": "Oncogene"}, {"key": "10.1002/gcc.2870050309-BIB26", "author": "Sanger", "volume": "74", "first-page": "5463", "year": "1977", "journal-title": "Proc Natl Acad Sci USA", "DOI": "10.1073/pnas.74.12.5463", "doi-asserted-by": "crossref"}, {"key": "10.1002/gcc.2870050309-BIB27", "author": "Schmid", "volume": "216", "first-page": "1065", "year": "1982", "journal-title": "Science", "DOI": "10.1126/science.6281889", "doi-asserted-by": "crossref"}, {"key": "10.1002/gcc.2870050309-BIB28", "author": "Singer", "volume": "10", "first-page": "119", "year": "1985", "journal-title": "Trends Biochem Sci", "DOI": "10.1016/0968-0004(85)90271-3", "doi-asserted-by": "crossref"}, {"key": "10.1002/gcc.2870050309-BIB29", "author": "Soekarman", "volume": "79", "first-page": "1", "year": "1992", "journal-title": "Blood"}, {"key": "10.1002/gcc.2870050309-BIB30", "author": "Strauss", "volume": "37", "first-page": "889", "year": "1984", "journal-title": "Cell", "DOI": "10.1016/0092-8674(84)90424-0", "doi-asserted-by": "crossref"}, {"key": "10.1002/gcc.2870050309-BIB31", "author": "Tonegawa", "volume": "302", "first-page": "575", "year": "1983", "journal-title": "Nature", "DOI": "10.1038/302575a0", "doi-asserted-by": "crossref"}, {"key": "10.1002/gcc.2870050309-BIB32", "author": "van der Feltz", "volume": "17", "first-page": "1", "year": "1989", "journal-title": "Nuclei. Acids Res", "DOI": "10.1093/nar/17.1.1", "doi-asserted-by": "crossref"}, {"key": "10.1002/gcc.2870050309-BIB33", "author": "von Lindern", "volume": "4", "first-page": "75", "year": "1989", "journal-title": "Oncogene"}, {"key": "10.1002/gcc.2870050309-BIB34", "author": "von Lindern", "volume": "10", "first-page": "4016", "year": "1990", "journal-title": "Mol Cell Biol", "DOI": "10.1128/MCB.10.8.4016", "doi-asserted-by": "crossref"}, {"key": "10.1002/gcc.2870050309-BIB35", "author": "von Lindern", "volume": "12", "first-page": "1687", "year": "1992a", "journal-title": "Mol Cell Bio", "DOI": "10.1128/MCB.12.4.1687", "doi-asserted-by": "crossref"}, {"key": "10.1002/gcc.2870050309-BIB36", "author": "von Lindern", "year": "1992b", "unstructured": ", , , , (1992b) Can, a putative oncogene associated with myeloid leukemogenesis, may be activated by fusion of its 3\u2032 half to different genes: Characterization of the set gene. Mol Cell Biol (in press)."}, {"key": "10.1002/gcc.2870050309-BIB37", "author": "Yancopoulos", "volume": "5", "first-page": "325", "year": "1986", "journal-title": "EMBO J", "DOI": "10.1002/j.1460-2075.1986.tb04637.x", "doi-asserted-by": "crossref"}], "container-title": ["Genes, Chromosomes and Cancer"], "language": "en", "link": [{"URL": "https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fgcc.2870050309", "content-type": "unspecified", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://onlinelibrary.wiley.com/doi/full/10.1002/gcc.2870050309", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 1, 17]], "date-time": "2019-01-17T21:26:23Z", "timestamp": 1547760383000}, "score": 70.0129, "issued": {"date-parts": [[1992, 10]]}, "references-count": 37, "journal-issue": {"published-print": {"date-parts": [[1992, 10]]}, "issue": "3"}, "URL": "http://dx.doi.org/10.1002/gcc.2870050309", "relation": {"cites": []}, "ISSN": ["1045-2257", "1098-2264"], "issn-type": [{"value": "1045-2257", "type": "print"}, {"value": "1098-2264", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T06:17:28Z", "timestamp": 1574144248444}, "reference-count": 49, "publisher": "Springer Science and Business Media LLC", "issue": "12", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[2002, 11, 26]], "date-time": "2002-11-26T00:00:00Z", "timestamp": 1038268800000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Leukemia"], "published-print": {"date-parts": [[2002, 12]]}, "DOI": "10.1038/sj.leu.2402742", "type": "journal-article", "created": {"date-parts": [[2002, 11, 28]], "date-time": "2002-11-28T11:59:38Z", "timestamp": 1038484778000}, "page": "2400-2407", "source": "Crossref", "is-referenced-by-count": 26, "title": ["Leukemia-associated fusion proteins, dek-can and bcr-abl, represent immunogenic HLA-DR-restricted epitopes recognized by fusion peptide-specific CD4+ T lymphocytes"], "prefix": "10.1038", "volume": "16", "author": [{"given": "M", "family": "Makita", "sequence": "first", "affiliation": []}, {"given": "T", "family": "Azuma", "sequence": "additional", "affiliation": []}, {"given": "H", "family": "Hamaguchi", "sequence": "additional", "affiliation": []}, {"given": "H", "family": "Niiya", "sequence": "additional", "affiliation": []}, {"given": "K", "family": "Kojima", "sequence": "additional", "affiliation": []}, {"given": "S", "family": "Fujita", "sequence": "additional", "affiliation": []}, {"given": "M", "family": "Tanimoto", "sequence": "additional", "affiliation": []}, {"given": "M", "family": "Harada", "sequence": "additional", "affiliation": []}, {"given": "M", "family": "Yasukawa", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2002, 11, 26]]}, "reference": [{"key": "BF2402742_CR1", "doi-asserted-by": "publisher", "first-page": "457", "DOI": "10.1084/jem.169.2.457", "volume": "169", "author": "JP Klarnet", "year": "1989", "unstructured": "Klarnet JP, Kern DE, Okunu K, Holt C, Lilly F, Greenberg PD . FBL-reactive CD8 cytotoxic and CD4 helper T cells recognize distinct Friend murine leukemia virus-encoded antigens J Exp Med 1989 169: 457\u2013467", "journal-title": "J Exp Med"}, {"key": "BF2402742_CR2", "doi-asserted-by": "publisher", "first-page": "1681", "DOI": "10.1084/jem.177.6.1681", "volume": "177", "author": "J Hu", "year": "1993", "unstructured": "Hu J, Kindsvogel W, Busby S, Bailey MC, Shi Y, Greenberg PD . An evaluation of the potential to use tumor-associated antigens as targets for antitumor T cell therapy using transgenic mice expressing a retroviral tumor antigen in normal lymphoid tissues J Exp Med 1993 177: 1681\u20131690", "journal-title": "J Exp Med"}, {"key": "BF2402742_CR3", "first-page": "4900", "volume": "150", "author": "A Yoshimura", "year": "1993", "unstructured": "Yoshimura A, Shiku H, Nakayama E . Rejection of an IA+ variant line of FBL-3 leukemia by cytotoxic T lymphocytes with CD4+ and CD4\u2212CD8\u2212 T cell receptor-\u03b1\u03b2 phenotypes generated in CD8-depleted C57BL/6 mice J Immunol 1993 150: 4900\u20134910", "journal-title": "J Immunol"}, {"key": "BF2402742_CR4", "first-page": "4337", "volume": "86", "author": "S Giralt", "year": "1995", "unstructured": "Giralt S, Hester J, Huh Y, Hirsch-Ginsberg C, Rondon G, Seong D, Lee M, Gajewski J, van Besien K, Khouri I, Mehra R, Przepiorka D, Korbling M, Talpaz M, Kantarjian H, Fischer H, Deisseroth A, Champlin R . CD8-depleted donor lymphocyte infusion as treatment for relapsed chronic myelogenous leukemia after allogeneic bone marrow transplantation Blood 1995 86: 4337\u20134343", "journal-title": "Blood"}, {"key": "BF2402742_CR5", "doi-asserted-by": "publisher", "first-page": "1351", "DOI": "10.1126/science.284.5418.1351", "volume": "284", "author": "R-F Wang", "year": "1999", "unstructured": "Wang R-F, Wang X, Atwood AC, Topalian SL, Rosenberg SA . Cloning genes encoding MHC class II-restricted antigens: mutated CDC27 as a tumor antigen Science 1999 284: 1351\u20131354", "journal-title": "Science"}, {"key": "BF2402742_CR6", "doi-asserted-by": "publisher", "first-page": "767", "DOI": "10.1084/jem.189.5.767", "volume": "189", "author": "P Chaux", "year": "1999", "unstructured": "Chaux P, Vantomme V, Stroobant V, Thielemans K, Corthals J, Luiten R, Eggermont AMM, Boon T, van der Bruggen P . Identification MAGE-3 epitopes presented by HLA-DR molecules to CD4+ T lymphocytes J Exp Med 1999 189: 767\u2013777", "journal-title": "J Exp Med"}, {"key": "BF2402742_CR7", "doi-asserted-by": "publisher", "first-page": "871", "DOI": "10.1084/jem.189.5.871", "volume": "189", "author": "S Manici", "year": "1999", "unstructured": "Manici S, Sturniolo T, Imro MA, Hammer J, Sinigaglia F, Noppen C, Spagnoli G, Mazzi B, Bellone M, Dellabona P, Protti MP . Melanoma cells present a MAGE-3 epitope to CD4+ cytotoxic T cells in association with histocompatibility leukocyte antigen DR11 J Exp Med 1999 189: 871\u2013876", "journal-title": "J Exp Med"}, {"key": "BF2402742_CR8", "first-page": "4773", "volume": "61", "author": "H Kobayashi", "year": "2001", "unstructured": "Kobayashi H, Song Y, Hoon DSB, Appella E, Celis E . Tumor-reactive T helper lymphocytes recognize a promiscuous MAGE-A3 epitope presented by various major histocompatibility complex class II alleles Cancer Res 2001 61: 4773\u20134778", "journal-title": "Cancer Res"}, {"key": "BF2402742_CR9", "first-page": "6272", "volume": "60", "author": "ES Schultz", "year": "2000", "unstructured": "Schultz ES, Leth\u00e9 B, Cambiaso CL, Van Snick J, Chaux P, Corthals J, Heirman C, Thielemans K, Boon T, van der Bruggen P . A MAGE-A3 peptide presented by HLA-DP4 is recognized on tumor cells by CD4+ cytolytic T lymphocytes Cancer Res 2000 60: 6272\u20136275", "journal-title": "Cancer Res"}, {"key": "BF2402742_CR10", "doi-asserted-by": "publisher", "first-page": "1153", "DOI": "10.4049/jimmunol.165.2.1153", "volume": "165", "author": "G Zeng", "year": "2000", "unstructured": "Zeng G, Touloukian CE, Wang X, Restifo NP, Rosenberg SA, Wang RF . Identification of CD4+ T cell epitopes from NY-ESO-1presented by HLA-DR molecules J Immunol 2000 165: 1153\u20131159", "journal-title": "J Immunol"}, {"key": "BF2402742_CR11", "doi-asserted-by": "publisher", "first-page": "3964", "DOI": "10.1073/pnas.061507398", "volume": "98", "author": "G Zeng", "year": "2001", "unstructured": "Zeng G, Wang X, Robbins PF, Rosenberg SA, Wang R-F . CD4+ T cell recognition of MHC class II-restricted epitopes from NY-ESO-1 presented by a prevalent HLA DP4 allele: association with NY-ESO-1 antibody production Proc Natl Acad Sci USA 2001 98: 3964\u20133969", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "BF2402742_CR12", "doi-asserted-by": "publisher", "first-page": "1965", "DOI": "10.1084/jem.183.5.1965", "volume": "183", "author": "SL Topalian", "year": "1996", "unstructured": "Topalian SL, Gonzales MI, Parkhurst M, Li YF, Southwood S, Sette A, Rosenberg SA, Robbins PF . Melanoma-specific CD4+ T cells recognize nonmutated HLA-DR-restricted tyrosinase epitopes J Exp Med 1996 183: 1965\u20131971", "journal-title": "J Exp Med"}, {"key": "BF2402742_CR13", "first-page": "296", "volume": "58", "author": "H Kobayashi", "year": "1998", "unstructured": "Kobayashi H, Kokubo T, Sato K, Kimura S, Asano K, Takahashi H, Iizuka H, Miyokawa N, Katagiri M . CD4+ T cells from peripheral blood of a melanoma patient recognize peptides derived from nonmutated tyrosinase Cancer Res 1998 58: 296\u2013301", "journal-title": "Cancer Res"}, {"key": "BF2402742_CR14", "doi-asserted-by": "publisher", "first-page": "400", "DOI": "10.1073/pnas.97.1.400", "volume": "97", "author": "HM Zarour", "year": "2000", "unstructured": "Zarour HM, Kirkwood JM, Kierstead LS, Herr W, Brusic V, Slingluff CL Jr, Sidney J, Sette A, Storkus WJ . Melan-A/MART-151-73 represents an immunogenic HLA-DR4-restricted epitope recognized by melanoma reactive CD4+ T cells Proc Natl Acad Sci USA 2000 97: 400\u2013405", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "BF2402742_CR15", "first-page": "5066", "volume": "58", "author": "EM Hiltbold", "year": "1998", "unstructured": "Hiltbold EM, Ciborowski P, Finn OJ . Naturally processed class II epitope from the tumor antigen MUC1 primes human CD4+ T cells Cancer Res 1998 58: 5066\u20135070", "journal-title": "Cancer Res"}, {"key": "BF2402742_CR16", "doi-asserted-by": "publisher", "first-page": "3535", "DOI": "10.4049/jimmunol.164.7.3535", "volume": "164", "author": "CE Touloukian", "year": "2000", "unstructured": "Touloukian CE, Leitner WW, Topalian SL, Li YF, Robbins PF, Rosenberg SA, Restifo NP . Identification of a MHC class II-restricted human gp100 epitope using DR4-IE transgenic mice J Immunol 2000 164: 3535\u20133542", "journal-title": "J Immunol"}, {"key": "BF2402742_CR17", "doi-asserted-by": "publisher", "first-page": "671", "DOI": "10.1007/s002620000163", "volume": "49", "author": "S Heinzel", "year": "2001", "unstructured": "Heinzel S, Rea D, Offringa R, Pawelec G . The self peptide annexin II (208-223) presented by dendritic cells sensitizes autologous CD4+ T lymphocytes to recognize melanoma cells Cancer Immunol Immunother 2001 49: 671\u2013678", "journal-title": "Cancer Immunol Immunother"}, {"key": "BF2402742_CR18", "first-page": "977", "volume": "91", "author": "M Nieda", "year": "1998", "unstructured": "Nieda M, Nicol A, Kikuchi A, Kashiwase K, Taylor K, Suzuki K, Tadokoro K, Juji T . Dendritic cells stimulate the expansion of bcr-abl specific CD8+ T cells with cytotoxic activity against leukemic cells from patients with chronic myeloid leukemia Blood 1998 91: 977\u2013983", "journal-title": "Blood"}, {"key": "BF2402742_CR19", "doi-asserted-by": "publisher", "first-page": "2290", "DOI": "10.1172/JCI488", "volume": "101", "author": "P Yotnda", "year": "1998", "unstructured": "Yotnda P, Firat H, Garcia-Pons F, Garcia Z, Gourru G, Vernant JP, Lemonnier FA, Leblond V, Langlade-Demoyen P . Cytotoxic T cell response against the chimeric p210 BCR-ABL protein in patients with chronic myelogenous leukemia J Clin Invest 1998 101: 2290\u20132296", "journal-title": "J Clin Invest"}, {"key": "BF2402742_CR20", "doi-asserted-by": "publisher", "first-page": "166", "DOI": "10.1038/sj.leu.2401311", "volume": "13", "author": "Y Osman", "year": "1999", "unstructured": "Osman Y, Takahashi M, Zheng Z, Koike T, Toba K, Liu A, Furukawa T, Aoki S, Aizawa Y . Generation of bcr-abl specific cytotoxic T lymphocytes by using dendritic cells pulsed with bcr-abl (b3a2) peptide: Its applicability for donor leukocyte transfusions in marrow grafted CML patients Leukemia 1999 13: 166\u2013174", "journal-title": "Leukemia"}, {"key": "BF2402742_CR21", "doi-asserted-by": "publisher", "first-page": "455", "DOI": "10.1172/JCI3126", "volume": "102", "author": "P Yotnda", "year": "1998", "unstructured": "Yotnda P, Garcia F, Peuchmaur M, Grandchamp B, Duval M, Lemonnier F, Vilmer E, Langlade-Demoyen P . Cytotoxic T cell response against the chimeric ETV6-AML1 protein in childhood acute lymphoblastic leukemia J Clin Invest 1998 102: 455\u2013462", "journal-title": "J Clin Invest"}, {"key": "BF2402742_CR22", "doi-asserted-by": "publisher", "first-page": "1249", "DOI": "10.1046/j.1365-2141.1998.00900.x", "volume": "102", "author": "H Hamaguchi", "year": "1998", "unstructured": "Hamaguchi H, Nagata K, Yamamoto K, Fujikawa I, Kobayashi M, Eguchi M . Establishment of a novel human myeloid leukaemia cell line (FKH-1) with t(6;9)(p23;q34) and the expression of dek-can chimaeric transcript Br J Haematol 1998 102: 1249\u20131256", "journal-title": "Br J Haematol"}, {"key": "BF2402742_CR23", "doi-asserted-by": "publisher", "first-page": "225", "DOI": "10.1084/jem.143.1.225", "volume": "143", "author": "BB Lozzio", "year": "1976", "unstructured": "Lozzio BB, Machado EA, Lozzio CB, Lair S . Hereditary asplenic-athymic mice: transplantation of human myelogenous leukemic cells J Exp Med 1976 143: 225\u2013231", "journal-title": "J Exp Med"}, {"key": "BF2402742_CR24", "first-page": "925", "volume": "93", "author": "H Ohminami", "year": "1999", "unstructured": "Ohminami H, Yasukawa M, Kaneko S, Yakushijin Y, Abe Y, Kasahara Y, Ishida Y, Fujita S . Fas-independent and nonapoptotic cytotoxicity mediated by a human CD4+ T-cell clone directed against an acute myelogenous leukemia-associated DEK-CAN fusion peptide Blood 1999 93: 925\u2013935", "journal-title": "Blood"}, {"key": "BF2402742_CR25", "first-page": "3355", "volume": "92", "author": "M Yasukawa", "year": "1998", "unstructured": "Yasukawa M, Ohminami H, Kaneko S, Yakushijin Y, Nishimura Y, Inokuchi K, Miyakuni T, Nakao S, Kishi K, Kubonishi I, Dan K, Fujita S . CD4+ cytotoxic T-cell clones specific for bcr-abl b3a2 fusion peptide augment colony formation by chronic myelogenous leukemia cells in a b3a2-specific and HLA-DR-restricted manner Blood 1998 92: 3355\u20133361", "journal-title": "Blood"}, {"key": "BF2402742_CR26", "first-page": "1341", "volume": "146", "author": "M Yasukawa", "year": "1991", "unstructured": "Yasukawa M, Inatsuki A, Horiuchi T, Kobayashi Y . Functional heterogeneity among herpes simplex virus-specific human CD4+ T cells J Immunol 1991 146: 1341\u20131347", "journal-title": "J Immunol"}, {"key": "BF2402742_CR27", "first-page": "3751", "volume": "71", "author": "Y Inoue", "year": "1997", "unstructured": "Inoue Y, Yasukawa M, Fujita S . Induction of T-cell apoptosis by human herpesvirus 6 J Virol 1997 71: 3751\u20133759", "journal-title": "J Virol"}, {"key": "BF2402742_CR28", "first-page": "286", "volume": "95", "author": "H Ohminami", "year": "2000", "unstructured": "Ohminami H, Yasukawa M, Fujita S . HLA class I-restricted lysis of leukemia cells by a CD8+ cytotoxic T lymphocyte clone specific for WT1 peptide Blood 2000 95: 286\u2013293", "journal-title": "Blood"}, {"key": "BF2402742_CR29", "doi-asserted-by": "publisher", "first-page": "305", "DOI": "10.1002/(SICI)1521-4141(199801)28:01<305::AID-IMMU305>3.0.CO;2-3", "volume": "28", "author": "H Fujita", "year": "1998", "unstructured": "Fujita H, Senju S, Yokomizo H, Saya H, Ogawa M, Matsushita S, Nishimura Y . Evidence that HLA class II-restricted human CD4+ T cells specific to p53 self peptides respond to p53 proteins of both wild and mutant forms Eur J Immunol 1998 28: 305\u2013316", "journal-title": "Eur J Immunol"}, {"key": "BF2402742_CR30", "doi-asserted-by": "publisher", "first-page": "588", "DOI": "10.1016/S0952-7915(98)80228-8", "volume": "10", "author": "DM Pardoll", "year": "1998", "unstructured": "Pardoll DM, Topalian SL . The role of CD4+ T cell responses in antitumor immunity Curr Opin Immunol 1998 10: 588\u2013594", "journal-title": "Curr Opin Immunol"}, {"key": "BF2402742_CR31", "doi-asserted-by": "publisher", "first-page": "269", "DOI": "10.1016/S1471-4906(01)01896-8", "volume": "22", "author": "R-F Wang", "year": "2001", "unstructured": "Wang R-F . The role of MHC class II-restricted tumor antigens and CD4+ T cells in antitumor immunity Trends Immunol 2001 22: 269\u2013276", "journal-title": "Trends Immunol"}, {"key": "BF2402742_CR32", "doi-asserted-by": "publisher", "first-page": "1687", "DOI": "10.1128/MCB.12.4.1687", "volume": "12", "author": "M von Lindern", "year": "1992", "unstructured": "von Lindern M, Fornerod M, van Baal S, Jaegie M, de Wit T, Buijs A, Grosveld G . The translocation (6;9), associated with a specific subtype of acute myeloid leukemia, results in the fusion of two genes, dek and can, and the expression of a chimeric, leukemia-specific dek-can mRNA Mol Cell Biol 1992 12: 1687\u20131697", "journal-title": "Mol Cell Biol"}, {"key": "BF2402742_CR33", "doi-asserted-by": "publisher", "first-page": "3902", "DOI": "10.4049/jimmunol.164.7.3902", "volume": "164", "author": "CN Baxevanis", "year": "2000", "unstructured": "Baxevanis CN, Voutsas IF, Tsitsilonis OE, Gritzapis AD, Sotiriadou R, Papamichail M . Tumor-specific CD4+ T lymphocytes from cancer patients are required for optimal induction of cytotoxic T cells against the autologous tumor J Immunol 2000 164: 3902\u20133912", "journal-title": "J Immunol"}, {"key": "BF2402742_CR34", "doi-asserted-by": "publisher", "first-page": "8633", "DOI": "10.1073/pnas.96.15.8633", "volume": "96", "author": "D Mumberg", "year": "1999", "unstructured": "Mumberg D, Monach PA, Wanderling S, Philip M, Toledano AY, Schreiber RD, Schreiber H . CD4+ T cells eliminate MHC class II-negative cancer cells in vivo by indirect effects of IFN-\u03b3 Proc Natl Acad Sci USA 1999 96: 8633\u20138638", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "BF2402742_CR35", "first-page": "422", "volume": "133", "author": "M Yasukawa", "year": "1984", "unstructured": "Yasukawa M, Zarling JM . Human cytotoxic T cell clones directed against herpes simplex virus-infected cells. I. Lysis restricted by HLA class II MB and DR antigens J Immunol 1984 133: 422\u2013427", "journal-title": "J Immunol"}, {"key": "BF2402742_CR36", "doi-asserted-by": "publisher", "first-page": "191", "DOI": "10.1111/j.1349-7006.1997.tb00365.x", "volume": "88", "author": "A Miyazaki", "year": "1997", "unstructured": "Miyazaki A, Sato N, Takahashi S, Sasaki A, Kohama G, Yamaguchi A, Yagihashi A, Kikuchi K . Cytotoxicity of histocompatibility leukocyte antigen-DR8-restricted CD4+ killer T cells against human autologous squamous cell carcinoma Jpn J Cancer Res 1997 88: 191\u2013197", "journal-title": "Jpn J Cancer Res"}, {"key": "BF2402742_CR37", "first-page": "1344", "volume": "9", "author": "GJ ten Bosch", "year": "1995", "unstructured": "ten Bosch GJ, Toornvliet AC, Friede T, Melief CJ, Leeksma OC . Recognition of peptides corresponding to the joining region of p210bcr-abl protein by human T cells Leukemia 1995 9: 1344\u20131348", "journal-title": "Leukemia"}, {"key": "BF2402742_CR38", "first-page": "2118", "volume": "88", "author": "G Pawelec", "year": "1996", "unstructured": "Pawelec G, Max H, Halder T, Bruserud O, Meri A, da Silva P, Kalbacher H . BCR/ABL leukemia oncogene fusion peptides selectively bind to certain HLA-DR alleles and can be recognized by T cells found at low frequency in the repertoire of normal donors Blood 1996 88: 2118\u20132124", "journal-title": "Blood"}, {"key": "BF2402742_CR39", "first-page": "3587", "volume": "87", "author": "M Bocchia", "year": "1996", "unstructured": "Bocchia M, Korontsvit T, Xu Q, Mackinnon S, Yang SY, Sette A, Scheinberg DA . Specific human cellular immunity to bcr-abl oncogene-derived peptides Blood 1996 87: 3587\u20133592", "journal-title": "Blood"}, {"key": "BF2402742_CR40", "first-page": "290", "volume": "90", "author": "SI Mannering", "year": "1997", "unstructured": "Mannering SI, McKenzie JL, Fearnley DB, Hart DNJ . HLA-DR1-restricted bcr-abl (b3a2)-specific CD4+ T lymphocytes respond to dendritic cells pulsed with b3a2 peptide and antigen-presenting cells exposed to b3a2 containing cell lysates Blood 1997 90: 290\u2013297", "journal-title": "Blood"}, {"key": "BF2402742_CR41", "first-page": "3522", "volume": "88", "author": "GJA ten Bosch", "year": "1996", "unstructured": "ten Bosch GJA, Joosten AM, Kessler JJ, Melief CJM, Leeksma OC . Recognition of bcr-abl positive leukemia blasts by human CD4+ T cells elicited by primary in vitro immunization with a bcr-abl breakpoint peptide Blood 1996 88: 3522\u20133527", "journal-title": "Blood"}, {"key": "BF2402742_CR42", "first-page": "1038", "volume": "94", "author": "GJA ten Bosch", "year": "1999", "unstructured": "ten Bosch GJA, Kessler JH, Joosten AM, Bres-Vloemans AA, Geluk A, Godtheip BC, van Bergen J, Melief CJ, Leeksma OC . A BCR-ABL oncoprotein p210b2a2 fusion region sequence is recognized by HLA-DR2a restricted cytotoxic T lymphocytes and presented by HLA-DR matched cells transfected with an Iib2a2 construct Blood 1999 94: 1038\u20131045", "journal-title": "Blood"}, {"key": "BF2402742_CR43", "doi-asserted-by": "publisher", "first-page": "1498", "DOI": "10.1182/blood.V98.5.1498", "volume": "98", "author": "M Yasukawa", "year": "2001", "unstructured": "Yasukawa M, Ohminami H, Kojima K, Hato T, Hasegawa A, Takahashi T, Hirai H, Fujita S . HLA class II-restricted antigen presentation of endogenous bcr-abl fusion protein by chronic myelogenous leukemia-derived dendritic cells to CD4+ T lymphocytes Blood 2001 98: 1498\u20131505", "journal-title": "Blood"}, {"key": "BF2402742_CR44", "doi-asserted-by": "publisher", "first-page": "693", "DOI": "10.1084/jem.187.5.693", "volume": "187", "author": "F Ossendorp", "year": "1998", "unstructured": "Ossendorp F, Mengede E, Camps M, Filius R, Melief CJM . Specific T helper cell requirement for optimal induction of cytotoxic T lymphocytes against major histocompatibility complex class II negative tumors J Exp Med 1998 187: 693\u2013702", "journal-title": "J Exp Med"}, {"key": "BF2402742_CR45", "doi-asserted-by": "publisher", "first-page": "86", "DOI": "10.1038/32183", "volume": "392", "author": "ML Albert", "year": "1998", "unstructured": "Albert ML, Sauter B, Bhardwaj N . Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs Nature 1998 392: 86\u201389", "journal-title": "Nature"}, {"key": "BF2402742_CR46", "first-page": "2150", "volume": "59", "author": "S Fujii", "year": "1999", "unstructured": "Fujii S, Fujimoto K, Shimizu K, Ezaki T, Kawano F, Takatsuki K, Kawakita M, Matsuno K . Presentation of tumor antigens by phagocytic dendritic cell clusters generated from human CD34+ hematopoietic progenitor cells: induction of autologous cytotoxic T lymphocytes against leukemia cells in acute myelogenous leukemia patients Cancer Res 1999 59: 2150\u20132158", "journal-title": "Cancer Res"}, {"key": "BF2402742_CR47", "doi-asserted-by": "publisher", "first-page": "2163", "DOI": "10.1084/jem.188.11.2163", "volume": "188", "author": "K Inaba", "year": "1998", "unstructured": "Inaba K, Turley S, Yamaide F, Iyoda T, Mahnke K, Inaba M, Pack M, Subkiewe M, Sauter B, Sheff D, Albert M, Bhardwaj N, Mellman I, Steinman RM . Efficient presentation of phagocytosed cellular fragments on the major histocompatibility complex class II products of dendritic cells J Exp Med 1998 188: 2163\u20132173", "journal-title": "J Exp Med"}, {"key": "BF2402742_CR48", "first-page": "6441", "volume": "60", "author": "M Shaif-Muthana", "year": "2000", "unstructured": "Shaif-Muthana M, McIntyre C, Sisley K, Rennie I, Murray A . Dead or alive: immunogenicity of human melanoma cells when presented by dendritic cells Cancer Res 2000 60: 6441\u20136447", "journal-title": "Cancer Res"}, {"key": "BF2402742_CR49", "doi-asserted-by": "publisher", "first-page": "423", "DOI": "10.1084/jem.191.3.423", "volume": "191", "author": "B Sauter", "year": "2000", "unstructured": "Sauter B, Albert ML, Francisco L, Larsson M, Somersan S, Bhardwaj N . Consequences of cell death: exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells J Exp Med 2000 191: 423\u2013433", "journal-title": "J Exp Med"}], "container-title": ["Leukemia"], "language": "en", "link": [{"URL": "http://www.nature.com/articles/2402742.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/2402742", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/2402742.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 3, 16]], "date-time": "2019-03-16T10:06:35Z", "timestamp": 1552730795000}, "score": 62.677776, "issued": {"date-parts": [[2002, 11, 26]]}, "references-count": 49, "journal-issue": {"published-print": {"date-parts": [[2002, 12]]}, "issue": "12"}, "alternative-id": ["BF2402742"], "URL": "http://dx.doi.org/10.1038/sj.leu.2402742", "relation": {"cites": []}, "ISSN": ["0887-6924", "1476-5551"], "issn-type": [{"value": "0887-6924", "type": "print"}, {"value": "1476-5551", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 26]], "date-time": "2019-11-26T01:41:03Z", "timestamp": 1574732463166}, "reference-count": 0, "publisher": "American Society for Microbiology", "issue": "8", "content-domain": {"domain": ["asm.org"], "crossmark-restriction": true}, "short-container-title": ["Mol. Cell. Biol."], "published-print": {"date-parts": [[1990, 8]]}, "abstract": "<jats:p>The specific (6;9)(p23;q34) chromosomal translocation is associated with a defined subtype of acute nonlymphocytic leukemia (ANLL). The 9q34 breakpoint is located at the telomeric side of the c-abl gene. Through a combination of chromosome jumping, long-range mapping, and chromosome walking, the chromosome 9 breakpoints of several t(6;9) ANLL patients were localized within a defined region of 8 kilobases (kb), 360 kb telomeric of c-abl. Subsequent cDNA cloning revealed that this region represented an intron in the middle of a gene, called Cain (can), encoding a 7.5-kb transcript. Disruption of the can gene by the translocation resulted in the expression of a new 5.5-kb can mRNA from the 6p- chromosome. Isolation of chromosome 6 sequences showed that breakpoints on 6p23 also clustered within a limited stretch of DNA. These data strongly suggest a direct involvement of the translocation in the leukemic process of t(6;9) ANLL.</jats:p>", "DOI": "10.1128/mcb.10.8.4016", "type": "journal-article", "created": {"date-parts": [[2015, 10, 1]], "date-time": "2015-10-01T21:58:12Z", "timestamp": 1443736692000}, "page": "4016-4026", "update-policy": "http://dx.doi.org/10.1128/asmj-crossmark-policy-page", "source": "Crossref", "is-referenced-by-count": 67, "title": ["The (6;9) chromosome translocation, associated with a specific subtype of acute nonlymphocytic leukemia, leads to aberrant transcription of a target gene on 9q34."], "prefix": "10.1128", "volume": "10", "author": [{"given": "M", "family": "von Lindern", "sequence": "first", "affiliation": []}, {"given": "A", "family": "Poustka", "sequence": "additional", "affiliation": []}, {"given": "H", "family": "Lerach", "sequence": "additional", "affiliation": []}, {"given": "G", "family": "Grosveld", "sequence": "additional", "affiliation": []}], "member": "235", "published-online": {"date-parts": [[1990, 8, 1]]}, "container-title": ["Molecular and Cellular Biology"], "language": "en", "link": [{"URL": "https://syndication.highwire.org/content/doi/10.1128/MCB.10.8.4016", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2016, 12, 23]], "date-time": "2016-12-23T07:39:34Z", "timestamp": 1482478774000}, "score": 55.286858, "issued": {"date-parts": [[1990, 8]]}, "references-count": 0, "journal-issue": {"published-online": {"date-parts": [[1990, 8, 1]]}, "published-print": {"date-parts": [[1990, 8]]}, "issue": "8"}, "alternative-id": ["10.1128/MCB.10.8.4016"], "URL": "http://dx.doi.org/10.1128/mcb.10.8.4016", "ISSN": ["0270-7306", "1098-5549"], "issn-type": [{"value": "0270-7306", "type": "print"}, {"value": "1098-5549", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T07:50:11Z", "timestamp": 1574495411417}, "reference-count": 74, "publisher": "Elsevier BV", "issue": "4", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[1992, 10, 1]], "date-time": "1992-10-01T00:00:00Z", "timestamp": 717897600000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Bailli\u00e8re's Clinical Haematology"], "published-print": {"date-parts": [[1992, 10]]}, "DOI": "10.1016/s0950-3536(11)80049-1", "type": "journal-article", "created": {"date-parts": [[2011, 2, 19]], "date-time": "2011-02-19T09:57:16Z", "timestamp": 1298109436000}, "page": "857-879", "source": "Crossref", "is-referenced-by-count": 42, "title": ["Translocation t(6;9) in acute non-lymphocytic leukaemia results in the formation of a DEK-CAN fusion gene"], "prefix": "10.1016", "volume": "5", "author": [{"given": "Marieke", "family": "Von Lindern", "sequence": "first", "affiliation": []}, {"given": "Maarten", "family": "Fornerod", "sequence": "additional", "affiliation": []}, {"given": "Nike", "family": "Soekarman", "sequence": "additional", "affiliation": []}, {"given": "Sjoz\u00e8f", "family": "Van Baal", "sequence": "additional", "affiliation": []}, {"given": "Martine", "family": "Jaegle", "sequence": "additional", "affiliation": []}, {"given": "Anne", "family": "Hagemeijer", "sequence": "additional", "affiliation": []}, {"given": "Dirk", "family": "Bootsma", "sequence": "additional", "affiliation": []}, {"given": "Gerard", "family": "Grosveld", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Bailli\u00e8re's Clinical Haematology"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0950353611800491?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0950353611800491?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 6, 8]], "date-time": "2019-06-08T17:23:26Z", "timestamp": 1560014606000}, "score": 53.747143, "issued": {"date-parts": [[1992, 10]]}, "references-count": 74, "journal-issue": {"published-print": {"date-parts": [[1992, 10]]}, "issue": "4"}, "alternative-id": ["S0950353611800491"], "URL": "http://dx.doi.org/10.1016/s0950-3536(11)80049-1", "ISSN": ["0950-3536"], "issn-type": [{"value": "0950-3536", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T05:53:28Z", "timestamp": 1574142808667}, "reference-count": 19, "publisher": "Springer Science and Business Media LLC", "issue": "1", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[2004, 10, 28]], "date-time": "2004-10-28T00:00:00Z", "timestamp": 1098921600000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Leukemia"], "published-print": {"date-parts": [[2005, 1]]}, "DOI": "10.1038/sj.leu.2403557", "type": "journal-article", "created": {"date-parts": [[2004, 10, 28]], "date-time": "2004-10-28T17:56:19Z", "timestamp": 1098986179000}, "page": "126-131", "source": "Crossref", "is-referenced-by-count": 8, "title": ["Development of a D-FISH method to detect DEK/CAN fusion resulting from t(6;9)(p23;q34) in patients with acute myelogenous leukemia"], "prefix": "10.1038", "volume": "19", "author": [{"given": "B M", "family": "Shearer", "sequence": "first", "affiliation": []}, {"given": "R A", "family": "Knudson", "sequence": "additional", "affiliation": []}, {"given": "H C", "family": "Flynn", "sequence": "additional", "affiliation": []}, {"given": "R P", "family": "Ketterling", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2004, 10, 28]]}, "reference": [{"key": "BF2403557_CR1", "author": "ES Jaffe", "first-page": "75", "year": "2001", "unstructured": "Jaffe ES, Harris NL, Stein H, Vardiman JW . World Health Organization Classification of Tumours: Pathology & Genetics of Tumours of Haematopoietic and Lymphoid Tissues. Lyon, France: International Agency for Research on Cancer, 2001, pp 75\u2013107.", "volume-title": "World Health Organization Classification of Tumours: Pathology & Genetics of Tumours of Haematopoietic and Lymphoid Tissues"}, {"key": "BF2403557_CR2", "first-page": "2990", "volume": "79", "author": "D Soekarman", "year": "1992", "unstructured": "Soekarman D, von Lindern M, Daenen S, de Jong B, Fonatsch C, Heinze B et al. The translocation (6;9)(p23;q34) shows consistent rearrangement of two genes and defines a myeloproliferative disorder with specific clinical features. Blood 1992; 79: 2990\u20132997.", "journal-title": "Blood"}, {"key": "BF2403557_CR3", "doi-asserted-by": "publisher", "first-page": "4016", "DOI": "10.1128/MCB.10.8.4016", "volume": "10", "author": "M von Lindern", "year": "1990", "unstructured": "von Lindern M, Poustka A, Lerach H, Grosveld G . The (6;9) chromosome translocation, associated with a specific subtype of acute nonlymphocytic leukemia, leads to aberrant transcription of a target gene on 9q34. Mol Cell Biol 1990; 10: 4016\u20134026.", "journal-title": "Mol Cell Biol"}, {"key": "BF2403557_CR4", "doi-asserted-by": "publisher", "first-page": "1687", "DOI": "10.1128/MCB.12.4.1687", "volume": "12", "author": "M von Lindern", "year": "1992", "unstructured": "von Lindern M, Fornerod M, van Baal S, Jaegle M, de Wit T, Buijs A et al. The translocation (6;9), associated with a specific subtype of acute myeloid leukemia, results in the fusion of two genes, dek and can, and the expression of a chimeric, leukemia-specific dek\u2013can mRNA. Mol Cell Biol 1992; 12: 1687\u20131697.", "journal-title": "Mol Cell Biol"}, {"key": "BF2403557_CR5", "doi-asserted-by": "publisher", "first-page": "195", "DOI": "10.1016/0165-4608(86)90155-X", "volume": "22", "author": "S Heim", "year": "1986", "unstructured": "Heim S, Kristoffersson U, Mandahl N, Mitelman F, Bekassy AN, Garwicz S et al. High resolution banding analysis of the reciprocal translocation t(6;9) in acute nonlymphocytic leukemia. Cancer Genet Cytogenet 1986; 22: 195\u2013201.", "journal-title": "Cancer Genet Cytogenet"}, {"key": "BF2403557_CR6", "first-page": "489", "volume": "6", "author": "D Soekarman", "year": "1992", "unstructured": "Soekarman D, von Lindern M, van der Plas DC, Selleri L, Bartram CRI, Martiat P et al. Dek\u2013Can rearrangement in translocation (6;9)(p23;q34). Leukemia 1992; 6: 489\u2013494.", "journal-title": "Leukemia"}, {"key": "BF2403557_CR7", "first-page": "1801", "volume": "13", "author": "M Fornerod", "year": "1996", "unstructured": "Fornerod M, Boer J, van Baal S, Morreau H, Grosveld G . Interaction of cellular proteins with the leukemia specific fusion proteins DEK\u2013CAN and SET\u2013CAN and their normal counterpart, the nucleoporin CAN. Oncogene 1996; 13: 1801\u20131808.", "journal-title": "Oncogene"}, {"key": "BF2403557_CR8", "doi-asserted-by": "publisher", "first-page": "1249", "DOI": "10.1046/j.1365-2141.1998.00900.x", "volume": "102", "author": "H Hamaguchi", "year": "1998", "unstructured": "Hamaguchi H, Nagata K, Yamamoto K, Fujikawa I, Kobayashi M, Eguchi M . Establishment of a novel human myeloid leukaemia cell line (FKH-1) with t(6;9)(p23;q34) and the expression of dek\u2013can chimaeric transcript. Br J. Haematol 1998; 102: 1249\u20131256.", "journal-title": "Br J. Haematol"}, {"key": "BF2403557_CR9", "doi-asserted-by": "publisher", "first-page": "299", "DOI": "10.1038/sj.leu.2400554", "volume": "11", "author": "J Boer", "year": "1997", "unstructured": "Boer J, Mahmoud H, Raimondi S, Grosveld G, Krance R . Loss of the DEK\u2013CAN fusion transcript in a child with t(6;9) acute myeloid leukemia following chemotherapy and allogeneic bone marrow transplantation. Leukemia 1997; 11: 299\u2013300.", "journal-title": "Leukemia"}, {"key": "BF2403557_CR10", "first-page": "3357", "volume": "91", "author": "GW Dewald", "year": "1998", "unstructured": "Dewald GW, Wyatt WA, Juneau AL, Carlson RO, Zinsmeister AR, Jalal SM et al. Highly sensitive fluorescence in situ hybridization method to detect double BCR/ABL fusion and monitor response to therapy in chronic myeloid leukemia. Blood 1998; 91: 3357\u20133365.", "journal-title": "Blood"}, {"key": "BF2403557_CR11", "doi-asserted-by": "publisher", "first-page": "59", "DOI": "10.1016/0165-4608(88)90312-3", "volume": "32", "author": "JL Spurbeck", "year": "1988", "unstructured": "Spurbeck JL, Carlson RO, Allen JE, Dewald GW . Culturing and robotic harvesting of bone marrow, lymph nodes, peripheral blood, fibroblasts, and solid tumors with in situ techniques. Cancer Genet Cytogenet 1988; 32: 59\u201366.", "journal-title": "Cancer Genet Cytogenet"}, {"key": "BF2403557_CR12", "doi-asserted-by": "publisher", "first-page": "3093", "DOI": "10.1182/blood-2003-05-1627", "volume": "102", "author": "A Pardanani", "year": "2003", "unstructured": "Pardanani A, Ketterling RP, Brockman SR, Flynn HC, Paternoster SF, Shearer BM et al. CHIC2 deletion, a surrogate for FIP1L1\u2013PDGFRA fusion, occurs in systemic mastocytosis associated with eosinophilia and predicts response to imatinib mesylate therapy. Blood 2003; 102: 3093\u20133096.", "journal-title": "Blood"}, {"key": "BF2403557_CR13", "doi-asserted-by": "publisher", "first-page": "144", "DOI": "10.1016/S0165-4608(03)00061-X", "volume": "145", "author": "SR Brockman", "year": "2003", "unstructured": "Brockman SR, Paternoster SF, Ketterling RP, Dewald GW . New highly sensitive fluorescence in situ hybridization method to detect PML/RARA fusion in acute promyelocytic leukemia. Cancer Genet Cytogenet 2003; 145: 144\u2013151.", "journal-title": "Cancer Genet Cytogenet"}, {"key": "BF2403557_CR14", "author": "YS Fan", "first-page": "334", "year": "2002", "unstructured": "Fan YS (ed). Methods in Molecular Biology. Totowa, NJ: Humana Press Inc., 2002; 204: 334\u2013338.", "volume-title": "Methods in Molecular Biology"}, {"key": "BF2403557_CR15", "doi-asserted-by": "publisher", "first-page": "1", "DOI": "10.1016/S0165-4608(03)00202-4", "volume": "148", "author": "SA Smoley", "year": "2004", "unstructured": "Smoley SA, Brockman SR, Paternoster SF, Meyer RG, Dewald GW . A novel tricolor, dual-fusion fluorescence in situ hybridization method to detect BCR/ABL fusion in cells with t(9;22)(q34;q11.2) associated with deletion of DNA on the derivative chromosome 9 in chronic myelocytic leukemia. Cancer Genet Cytogenet 2004; 148: 1\u20136.", "journal-title": "Cancer Genet Cytogenet"}, {"key": "BF2403557_CR16", "first-page": "738", "volume": "95", "author": "PB Sinclair", "year": "2000", "unstructured": "Sinclair PB, Nacheva EP, Leversha M, Telford N, Chang J, Reid A et al. Large deletions at the t(9;22) breakpoint are common and may identify a poor-prognosis subgroup of patients with chronic myeloid leukemia. Blood 2000; 95: 738\u2013744.", "journal-title": "Blood"}, {"key": "BF2403557_CR17", "doi-asserted-by": "publisher", "first-page": "3581", "DOI": "10.1182/blood.V97.11.3581", "volume": "97", "author": "E Kolomietz", "year": "2001", "unstructured": "Kolomietz E, Al-Maghrabi J, Brennan S, Karaskova J, Minkin S, Lipton J et al. Primary chromosomal rearrangements of leukemia are frequently accompanied by extensive submicroscopic deletions and may lead to altered prognosis. Blood 2001; 97: 3581\u20133588.", "journal-title": "Blood"}, {"key": "BF2403557_CR18", "doi-asserted-by": "publisher", "first-page": "1752", "DOI": "10.1038/sj.leu.2402585", "volume": "16", "author": "C Godon", "year": "2002", "unstructured": "Godon C, Proffitt J, Dastugue N, Lafage-Pochitaloff M, Mozziconacci M-J, Talmant P et al. Large deletions 5\u2032 to the ETO breakpoint are recurrent events in patients with t(8;21) acute myeloid leukemia. Leukemia 2002; 16: 1752\u20131754.", "journal-title": "Leukemia"}, {"key": "BF2403557_CR19", "doi-asserted-by": "publisher", "first-page": "97", "DOI": "10.1002/gcc.1171", "volume": "32", "author": "YL Wang", "year": "2001", "unstructured": "Wang YL, Bagg A, Pear W, Nowell PC, Hess JL . Chronic myelogenous leukemia: laboratory diagnosis and monitoring. Genes Chromos Cancer 2001; 32: 97\u2013111.", "journal-title": "Genes Chromos Cancer"}], "container-title": ["Leukemia"], "language": "en", "link": [{"URL": "http://www.nature.com/articles/2403557.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/2403557", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/2403557.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 3, 16]], "date-time": "2019-03-16T10:40:54Z", "timestamp": 1552732854000}, "score": 51.31801, "issued": {"date-parts": [[2004, 10, 28]]}, "references-count": 19, "journal-issue": {"published-print": {"date-parts": [[2005, 1]]}, "issue": "1"}, "alternative-id": ["BF2403557"], "URL": "http://dx.doi.org/10.1038/sj.leu.2403557", "relation": {"cites": []}, "ISSN": ["0887-6924", "1476-5551"], "issn-type": [{"value": "0887-6924", "type": "print"}, {"value": "1476-5551", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 22]], "date-time": "2019-11-22T22:57:59Z", "timestamp": 1574463479199}, "reference-count": 29, "publisher": "Springer Science and Business Media LLC", "issue": "11", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[2010, 9, 9]], "date-time": "2010-09-09T00:00:00Z", "timestamp": 1283990400000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Leukemia"], "published-print": {"date-parts": [[2010, 11]]}, "DOI": "10.1038/leu.2010.180", "type": "journal-article", "created": {"date-parts": [[2010, 9, 9]], "date-time": "2010-09-09T10:22:48Z", "timestamp": 1284027768000}, "page": "1910-1919", "source": "Crossref", "is-referenced-by-count": 25, "title": ["The t(6;9) associated DEK/CAN fusion protein targets a population of long-term repopulating hematopoietic stem cells for leukemogenic transformation"], "prefix": "10.1038", "volume": "24", "author": [{"given": "C", "family": "Oancea", "sequence": "first", "affiliation": []}, {"given": "B", "family": "R\u00fcster", "sequence": "additional", "affiliation": []}, {"given": "R", "family": "Henschler", "sequence": "additional", "affiliation": []}, {"given": "E", "family": "Puccetti", "sequence": "additional", "affiliation": []}, {"given": "M", "family": "Ruthardt", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2010, 9, 9]]}, "reference": [{"key": "BFleu2010180_CR1", "doi-asserted-by": "publisher", "first-page": "11842", "DOI": "10.1073/pnas.2034201100", "volume": "100", "author": "E Passegu\u00e9", "year": "2003", "unstructured": "Passegu\u00e9 E, Jamieson CHM, Ailles LE, Weissman IL . Normal and leukemic hematopoiesis: are leukemias a stem cell disorder or a reacquisition of stem cell characteristics? Proc Natl Acad Sci USA 2003; 100: 11842\u201311849.", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "BFleu2010180_CR2", "doi-asserted-by": "publisher", "first-page": "1059", "DOI": "10.1126/science.278.5340.1059", "volume": "278", "author": "AT Look", "year": "1997", "unstructured": "Look AT . Oncogenic transcription factors in the human acute leukemias. Science 1997; 278: 1059\u20131064.", "journal-title": "Science"}, {"key": "BFleu2010180_CR3", "first-page": "7050", "volume": "62", "author": "E Puccetti", "year": "2002", "unstructured": "Puccetti E, Obradovic D, Beissert T, Bianchini A, Washburn B, Chiaradonna F et al. AML-associated translocation products block vitamin D(3)-induced differentiation by sequestering the vitamin D(3) receptor. Cancer Res 2002; 62: 7050\u20137058.", "journal-title": "Cancer Res"}, {"key": "BFleu2010180_CR4", "doi-asserted-by": "publisher", "first-page": "945", "DOI": "10.1038/nm1443", "volume": "12", "author": "M Yan", "year": "2006", "unstructured": "Yan M, Kanbe E, Peterson LF, Boyapati A, Miao Y, Wang Y et al. A previously unidentified alternatively spliced isoform of t(8;21) transcript promotes leukemogenesis. Nat Med 2006; 12: 945\u2013949.", "journal-title": "Nat Med"}, {"key": "BFleu2010180_CR5", "doi-asserted-by": "publisher", "first-page": "3535", "DOI": "10.1182/blood-2003-09-3335", "volume": "103", "author": "X Zheng", "year": "2004", "unstructured": "Zheng X, Beissert T, Kukoc-Zivojnov N, Puccetti E, Altschmied J, Strolz C et al. Gamma-catenin contributes to leukemogenesis induced by AML-associated translocation products by increasing the self-renewal of very primitive progenitor cells. Blood 2004; 103: 3535\u20133543.", "journal-title": "Blood"}, {"key": "BFleu2010180_CR6", "doi-asserted-by": "publisher", "first-page": "126", "DOI": "10.1038/sj.leu.2403557", "volume": "19", "author": "BM Shearer", "year": "2005", "unstructured": "Shearer BM, Knudson RA, Flynn HC, Ketterling RP . Development of a D-FISH method to detect DEK/CAN fusion resulting from t(6;9)(p23;q34) in patients with acute myelogenous leukemia. Leukemia 2005; 19: 126\u2013131.", "journal-title": "Leukemia"}, {"key": "BFleu2010180_CR7", "first-page": "489", "volume": "6", "author": "D Soekarman", "year": "1992", "unstructured": "Soekarman D, von Lindern M, van der Plas SDC, Selleri L, Bartram C, Martiat P et al. Dek-can rearrangment in translocation (6;9)(p23;q34). Leukemia 1992; 6: 489\u2013494.", "journal-title": "Leukemia"}, {"key": "BFleu2010180_CR8", "first-page": "1835", "volume": "132", "author": "Y Chi", "year": "2008", "unstructured": "Chi Y, Lindgren V, Quigley S, Gaitonde S . Acute myelogenous leukemia with t(6;9)(p23;q34) and marrow basophilia: an overview. Arch Pathol Lab Med 2008; 132: 1835\u20131837.", "journal-title": "Arch Pathol Lab Med"}, {"key": "BFleu2010180_CR9", "doi-asserted-by": "publisher", "first-page": "1338", "DOI": "10.1038/sj.leu.2403835", "volume": "19", "author": "L Gar\u00e7on", "year": "2005", "unstructured": "Gar\u00e7on L, Libura M, Delabesse E, Valensi F, Asnafi V, Berger C et al. DEK-CAN molecular monitoring of myeloid malignancies could aid therapeutic stratification. Leukemia 2005; 19: 1338\u20131344.", "journal-title": "Leukemia"}, {"key": "BFleu2010180_CR10", "doi-asserted-by": "publisher", "first-page": "1687", "DOI": "10.1128/MCB.12.4.1687", "volume": "12", "author": "M von Lindern", "year": "1992", "unstructured": "von Lindern M, Fornerod M, van Baal S, Jaegle M, de Wit T, Buijs A et al. The translocation (6;9), associated with a specific subtype of acute myeloid leukemia, results in the fusion of two genes, dek and can, and the expression of a chimeric, leukemia-specific dek-can mRNA. Mol Cell Biol 1992; 12: 1687\u20131697.", "journal-title": "Mol Cell Biol"}, {"key": "BFleu2010180_CR11", "doi-asserted-by": "publisher", "first-page": "348", "DOI": "10.1309/5DGB59KQA527PD47", "volume": "122", "author": "MP Oyarzo", "year": "2004", "unstructured": "Oyarzo MP, Lin P, Glassman A, Bueso-Ramos CE, Luthra R, Medeiros LJ . Acute myeloid leukemia with t(6;9)(p23;q34) is associated with dysplasia and a high frequency of flt3 gene mutations. Am J Clin Pathol 2004; 122: 348\u2013358.", "journal-title": "Am J Clin Pathol"}, {"key": "BFleu2010180_CR12", "first-page": "3319", "volume": "115", "author": "AD Hollenbach", "year": "2002", "unstructured": "Hollenbach AD, McPherson CJ, Mientjes EJ, Iyengar R, Grosveld G . Daxx and histone deacetylase II associate with chromatin through an interaction with core histones and the chromatin-associated protein Dek. J Cell Sci 2002; 115: 3319\u20133330.", "journal-title": "J Cell Sci"}, {"key": "BFleu2010180_CR13", "doi-asserted-by": "publisher", "first-page": "3217", "DOI": "10.1016/j.febslet.2006.04.081", "volume": "580", "author": "SI Ko", "year": "2006", "unstructured": "Ko SI, Lee IS, Kim JY, Kim SM, Kim DW, Lee KS et al. Regulation of histone acetyltransferase activity of p300 and PCAF by proto-oncogene protein DEK. FEBS Lett 2006; 580: 3217\u20133222.", "journal-title": "FEBS Lett"}, {"key": "BFleu2010180_CR14", "doi-asserted-by": "publisher", "first-page": "6000", "DOI": "10.1128/MCB.24.13.6000-6010.2004", "volume": "24", "author": "F Kappes", "year": "2004", "unstructured": "Kappes F, Scholten I, Richter N, Gruss C, Waldmann T . Functional domains of the ubiquitous chromatin protein DEK. Mol Cell Biol 2004; 24: 6000\u20136010.", "journal-title": "Mol Cell Biol"}, {"key": "BFleu2010180_CR15", "doi-asserted-by": "publisher", "first-page": "24988", "DOI": "10.1074/jbc.M204045200", "volume": "277", "author": "T Waldmann", "year": "2002", "unstructured": "Waldmann T, Eckerich C, Baack M, Gruss C . The ubiquitous chromatin protein DEK alters the structure of DNA by introducing positive supercoils. J Biol Chem 2002; 277: 24988\u201324994.", "journal-title": "J Biol Chem"}, {"key": "BFleu2010180_CR16", "doi-asserted-by": "publisher", "first-page": "14309", "DOI": "10.1128/JVI.79.22.14309-14317.2005", "volume": "79", "author": "TM Wise-Draper", "year": "2005", "unstructured": "Wise-Draper TM, Allen HV, Thobe MN, Jones EE, Habash KB, M\u00fcnger K et al. The human DEK proto-oncogene is a senescence inhibitor and an upregulated target of high-risk human papillomavirus E7. J Virol 2005; 79: 14309\u201314317.", "journal-title": "J Virol"}, {"key": "BFleu2010180_CR17", "doi-asserted-by": "publisher", "first-page": "807", "DOI": "10.1093/emboj/16.4.807", "volume": "16", "author": "M Fornerod", "year": "1997", "unstructured": "Fornerod M, van Deursen J, van Baal S, Reynolds A, Davis D, Murti KG et al. The human homologue of yeast CRM1 is in a dynamic subcomplex with CAN/Nup214 and a novel nuclear pore component Nup88. EMBO J 1997; 16: 807\u2013816.", "journal-title": "EMBO J"}, {"key": "BFleu2010180_CR18", "doi-asserted-by": "publisher", "first-page": "1236", "DOI": "10.1128/MCB.18.3.1236", "volume": "18", "author": "J Boer", "year": "1998", "unstructured": "Boer J, Bonten-Surtel J, Grosveld G . Overexpression of the nucleoporin CAN/NUP214 induces growth arrest, nucleocytoplasmic transport defects, and apoptosis. Mol Cell Biol. 1998; 18: 1236\u20131247.", "journal-title": "Mol Cell Biol."}, {"key": "BFleu2010180_CR19", "first-page": "268", "volume": "91", "author": "M Ageberg", "year": "2006", "unstructured": "Ageberg M, Gullberg U, Lindmark A . The involvement of cellular proliferation status in the expression of the human proto-oncogene DEK. Haematologica 2006; 91: 268\u2013269.", "journal-title": "Haematologica"}, {"key": "BFleu2010180_CR20", "doi-asserted-by": "publisher", "first-page": "2744", "DOI": "10.1002/ijc.23467", "volume": "122", "author": "T Beissert", "year": "2008", "unstructured": "Beissert T, Hundertmark A, Kaburova V, Travaglini L, Mian AA, Nervi C et al. Targeting of the N-terminal coiled coil oligomerization interface by a helix-2 peptide inhibits unmutated and imatinib-resistant BCR/ABL. Int J Cancer 2008; 122: 2744\u20132752.", "journal-title": "Int J Cancer"}, {"key": "BFleu2010180_CR21", "doi-asserted-by": "publisher", "first-page": "323", "DOI": "10.3324/haematol.10541", "volume": "92", "author": "X Zheng", "year": "2007", "unstructured": "Zheng X, Seshire A, R\u00fcster B, Bug G, Beissert T, Puccetti E . Arsenic but not all-trans retinoic acid overcomes the aberrant stem cell capacity of PML/RARalpha-positive leukemic stem cells. Haematologica 2007; 92: 323\u2013331.", "journal-title": "Haematologica"}, {"key": "BFleu2010180_CR22", "doi-asserted-by": "publisher", "first-page": "2537", "DOI": "10.1158/0008-5472.CAN-04-3011", "volume": "65", "author": "G Bug", "year": "2005", "unstructured": "Bug G, G\u00fcl H, Schwarz K, Pfeifer H, Kampfmann M, Zheng X et al. Valproic acid stimulates proliferation and self-renewal of hematopoietic stem cells. Cancer Res 2005; 65: 2537\u20132541.", "journal-title": "Cancer Res"}, {"key": "BFleu2010180_CR23", "doi-asserted-by": "publisher", "first-page": "587", "DOI": "10.1016/j.ccr.2004.10.015", "volume": "6", "author": "BJP Huntly", "year": "2004", "unstructured": "Huntly BJP, Shigematsu H, Deguchi K, Lee BH, Mizuno S, Duclos N et al. MOZ-TIF2, but not BCR-ABL, confers properties of leukemic stem cells to committed murine hematopoietic progenitors. Cancer Cell 2004; 6: 587\u2013596.", "journal-title": "Cancer Cell"}, {"key": "BFleu2010180_CR24", "doi-asserted-by": "publisher", "first-page": "7210", "DOI": "10.1038/sj.onc.1207941", "volume": "23", "author": "L Coulombel", "year": "2004", "unstructured": "Coulombel L . Identification of hematopoietic stem/progenitor cells: strength and drawbacks of functional assays. Oncogene 2004; 23: 7210\u20137222.", "journal-title": "Oncogene"}, {"key": "BFleu2010180_CR25", "doi-asserted-by": "publisher", "first-page": "363", "DOI": "10.1016/j.ccr.2006.08.023", "volume": "10", "author": "AJ Deshpande", "year": "2006", "unstructured": "Deshpande AJ, Cusan M, Rawat VPS, Reuter H, Krause A, Pott C et al. Acute myeloid leukemia is propagated by a leukemic stem cell with lymphoid characteristics in a mouse model of CALM/AF10-positive leukemia. Cancer Cell 2006; 10: 363\u2013374.", "journal-title": "Cancer Cell"}, {"key": "BFleu2010180_CR26", "doi-asserted-by": "publisher", "first-page": "51", "DOI": "10.1038/nature07618", "volume": "457", "author": "A Viale", "year": "2009", "unstructured": "Viale A, Franco FD, Orleth A, Cambiaghi V, Giuliani V, Bossi D et al. Cell-cycle restriction limits DNA damage and maintains self-renewal of leukaemia stem cells. Nature 2009; 457: 51\u201356.", "journal-title": "Nature"}, {"key": "BFleu2010180_CR27", "doi-asserted-by": "publisher", "first-page": "5415", "DOI": "10.1182/blood-2008-10-182071", "volume": "114", "author": "FC Guibal", "year": "2009", "unstructured": "Guibal FC, Alberich-Jorda M, Hirai H, Ebralidze A, Levantini E, Ruscio AD et al. Identification of a myeloid committed progenitor as the cancer-initiating cell in acute promyelocytic leukemia. Blood 2009; 114: 5415\u20135425.", "journal-title": "Blood"}, {"key": "BFleu2010180_CR28", "doi-asserted-by": "publisher", "first-page": "1462", "DOI": "10.1038/leu.2009.63", "volume": "23", "author": "S Wojiski", "year": "2009", "unstructured": "Wojiski S, Guibal FC, Kindler T, Lee BH, Jesneck JL, Fabian A et al. PML-RARalpha initiates leukemia by conferring properties of self-renewal to committed promyelocytic progenitors. Leukemia 2009; 23: 1462\u20131471.", "journal-title": "Leukemia"}, {"key": "BFleu2010180_CR29", "doi-asserted-by": "publisher", "first-page": "494", "DOI": "10.1016/j.tcb.2005.07.004", "volume": "15", "author": "JC Wang", "year": "2005", "unstructured": "Wang JC, Dick JE . Cancer stem cells: lessons from leukemia. Trends Cell Biol 2005; 15: 494\u2013501.", "journal-title": "Trends Cell Biol"}], "container-title": ["Leukemia"], "language": "en", "link": [{"URL": "http://www.nature.com/articles/leu2010180.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/leu2010180", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/leu2010180.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 4, 19]], "date-time": "2019-04-19T14:10:55Z", "timestamp": 1555683055000}, "score": 48.575146, "issued": {"date-parts": [[2010, 9, 9]]}, "references-count": 29, "journal-issue": {"published-print": {"date-parts": [[2010, 11]]}, "issue": "11"}, "alternative-id": ["BFleu2010180"], "URL": "http://dx.doi.org/10.1038/leu.2010.180", "relation": {"cites": []}, "ISSN": ["0887-6924", "1476-5551"], "issn-type": [{"value": "0887-6924", "type": "print"}, {"value": "1476-5551", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 18]], "date-time": "2019-11-18T17:26:34Z", "timestamp": 1574097994262}, "reference-count": 7, "publisher": "Elsevier BV", "issue": "5", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[1995, 5, 1]], "date-time": "1995-05-01T00:00:00Z", "timestamp": 799286400000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Leukemia Research"], "published-print": {"date-parts": [[1995, 5]]}, "DOI": "10.1016/0145-2126(95)00020-o", "type": "journal-article", "created": {"date-parts": [[2002, 7, 25]], "date-time": "2002-07-25T15:23:32Z", "timestamp": 1027610612000}, "page": "357-358", "source": "Crossref", "is-referenced-by-count": 2, "title": ["Translocation (8;21) in acute myeloid leukemia: When to treat? That is the question!!"], "prefix": "10.1016", "volume": "19", "author": [{"given": "John M.", "family": "Bennett", "sequence": "first", "affiliation": []}], "member": "78", "container-title": ["Leukemia Research"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:014521269500020O?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:014521269500020O?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 4, 27]], "date-time": "2019-04-27T07:56:42Z", "timestamp": 1556351802000}, "score": 45.797256, "issued": {"date-parts": [[1995, 5]]}, "references-count": 7, "journal-issue": {"published-print": {"date-parts": [[1995, 5]]}, "issue": "5"}, "alternative-id": ["014521269500020O"], "URL": "http://dx.doi.org/10.1016/0145-2126(95)00020-o", "ISSN": ["0145-2126"], "issn-type": [{"value": "0145-2126", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 30]], "date-time": "2019-11-30T23:46:28Z", "timestamp": 1575157588454}, "reference-count": 36, "publisher": "Springer Science and Business Media LLC", "issue": "8", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[2005, 6, 23]], "date-time": "2005-06-23T00:00:00Z", "timestamp": 1119484800000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Leukemia"], "published-print": {"date-parts": [[2005, 8]]}, "DOI": "10.1038/sj.leu.2403835", "type": "journal-article", "created": {"date-parts": [[2005, 6, 23]], "date-time": "2005-06-23T10:43:22Z", "timestamp": 1119523402000}, "page": "1338-1344", "source": "Crossref", "is-referenced-by-count": 31, "title": ["DEK-CAN molecular monitoring of myeloid malignancies could aid therapeutic stratification"], "prefix": "10.1038", "volume": "19", "author": [{"given": "L", "family": "Gar\u00e7on", "sequence": "first", "affiliation": []}, {"given": "M", "family": "Libura", "sequence": "additional", "affiliation": []}, {"given": "E", "family": "Delabesse", "sequence": "additional", "affiliation": []}, {"given": "F", "family": "Valensi", "sequence": "additional", "affiliation": []}, {"given": "V", "family": "Asnafi", "sequence": "additional", "affiliation": []}, {"given": "C", "family": "Berger", "sequence": "additional", "affiliation": []}, {"given": "C", "family": "Schmitt", "sequence": "additional", "affiliation": []}, {"given": "T", "family": "Leblanc", "sequence": "additional", "affiliation": []}, {"given": "A", "family": "Buzyn", "sequence": "additional", "affiliation": []}, {"given": "E", "family": "Macintyre", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2005, 6, 23]]}, "reference": [{"key": "BF2403835_CR1", "first-page": "705", "volume": "47", "author": "JD Rowley", "year": "1976", "unstructured": "Rowley JD, Potter D . Chromosomal banding patterns in acute nonlymphocytic leukemia. Blood 1976; 47: 705\u2013721.", "journal-title": "Blood"}, {"key": "BF2403835_CR2", "first-page": "527", "volume": "7", "author": "DM Lillington", "year": "1993", "unstructured": "Lillington DM, MacCallum PK, Lister TA, Gibbons B . Translocation t(6;9)(p23;q34) in acute myeloid leukemia without myelodysplasia or basophilia: two cases and a review of the literature. Leukemia 1993; 7: 527\u2013531.", "journal-title": "Leukemia"}, {"key": "BF2403835_CR3", "doi-asserted-by": "publisher", "first-page": "430", "DOI": "10.1093/ajcp/107.4.430", "volume": "107", "author": "R Alsabeh", "year": "1997", "unstructured": "Alsabeh R, Brynes RK, Slovak ML, Arber DA . Acute myeloid leukemia with t(6;9)(p23;q34): association with myelodysplasia, basophilia, and initial CD34 negative immunophenotype. Am J Clin Pathol 1997; 107: 430\u2013437.", "journal-title": "Am J Clin Pathol"}, {"key": "BF2403835_CR4", "first-page": "2990", "volume": "79", "author": "D Soekarman", "year": "1992", "unstructured": "Soekarman D, von Lindern M, Daenen S, de Jong B, Fonatsch C, Heinze B et al. The translocation (6;9)(p23;q34) shows consistent rearrangement of two genes and defines a myeloproliferative disorder with specific clinical features. Blood 1992; 79: 2990\u20132997.", "journal-title": "Blood"}, {"key": "BF2403835_CR5", "doi-asserted-by": "publisher", "first-page": "57", "DOI": "10.1016/S0165-4608(98)00256-8", "volume": "112", "author": "MY Shapira", "year": "1999", "unstructured": "Shapira MY, Hirshberg B, Amir G, Rund D . (6;9) translocation in myelodysplastic syndrome. Cancer Genet Cytogenet 1999; 112: 57\u201359.", "journal-title": "Cancer Genet Cytogenet"}, {"key": "BF2403835_CR6", "doi-asserted-by": "publisher", "first-page": "4016", "DOI": "10.1128/MCB.10.8.4016", "volume": "10", "author": "M von Lindern", "year": "1990", "unstructured": "von Lindern M, Poustka A, Lerach H, Grosveld G . The (6;9) chromosome translocation, associated with a specific subtype of acute nonlymphocytic leukemia, leads to aberrant transcription of a target gene on 9q34. Mol Cell Biol 1990; 10: 4016\u20134026.", "journal-title": "Mol Cell Biol"}, {"key": "BF2403835_CR7", "doi-asserted-by": "publisher", "first-page": "24988", "DOI": "10.1074/jbc.M204045200", "volume": "277", "author": "T Waldmann", "year": "2002", "unstructured": "Waldmann T, Eckerich C, Baack M, Gruss C . The ubiquitous chromatin protein DEK alters the structure of DNA by introducing positive supercoils. J Biol Chem 2002; 277: 24988\u201324994.", "journal-title": "J Biol Chem"}, {"key": "BF2403835_CR8", "doi-asserted-by": "publisher", "first-page": "7003", "DOI": "10.1093/nar/gkg864", "volume": "31", "author": "T Waldmann", "year": "2003", "unstructured": "Waldmann T, Baack M, Richter N, Gruss C . Structure-specific binding of the proto-oncogene protein DEK to DNA. Nucleic Acids Res 2003; 31: 7003\u20137010.", "journal-title": "Nucleic Acids Res"}, {"key": "BF2403835_CR9", "doi-asserted-by": "publisher", "first-page": "1935", "DOI": "10.1080/1042819031000119299", "volume": "44", "author": "S Casas", "year": "2003", "unstructured": "Casas S, Nagy B, Elonen E, Aventin A, Larramendy ML, Sierra J et al. Aberrant expression of HOXA9, DEK, CBL and CSF1R in acute myeloid leukemia. Leuk Lymphoma 2003; 44: 1935\u20131941.", "journal-title": "Leuk Lymphoma"}, {"key": "BF2403835_CR10", "doi-asserted-by": "publisher", "first-page": "1236", "DOI": "10.1128/MCB.18.3.1236", "volume": "18", "author": "J Boer", "year": "1998", "unstructured": "Boer J, Bonten-Surtel J, Grosveld G . Overexpression of the nucleoporin CAN/NUP214 induces growth arrest, nucleocytoplasmic transport defects, and apoptosis. Mol Cell Biol 1998; 18: 1236\u20131247.", "journal-title": "Mol Cell Biol"}, {"key": "BF2403835_CR11", "doi-asserted-by": "publisher", "first-page": "1519", "DOI": "10.1073/pnas.91.4.1519", "volume": "91", "author": "D Kraemer", "year": "1994", "unstructured": "Kraemer D, Wozniak RW, Blobel G, Radu A . The human CAN protein, a putative oncogene product associated with myeloid leukemogenesis, is a nuclear pore complex protein that faces the cytoplasm. Proc Natl Acad Sci USA 1994; 91: 1519\u20131523.", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "BF2403835_CR12", "doi-asserted-by": "publisher", "first-page": "227", "DOI": "10.1002/gcc.2870050309", "volume": "5", "author": "M von Lindern", "year": "1992", "unstructured": "von Lindern M, Breems D, van Baal S, Adriaansen H, Grosveld G . Characterization of the translocation breakpoint sequences of two DEK-CAN fusion genes present in t(6;9) acute myeloid leukemia and a SET-CAN fusion gene found in a case of acute undifferentiated leukemia. Genes Chromosomes Cancer 1992; 5: 227\u2013234.", "journal-title": "Genes Chromosomes Cancer"}, {"key": "BF2403835_CR13", "doi-asserted-by": "publisher", "first-page": "1084", "DOI": "10.1038/ng1425", "volume": "36", "author": "C Graux", "year": "2004", "unstructured": "Graux C, Cools J, Melotte C, Quentmeier H, Ferrando A, Levine R et al. Fusion of NUP214 to ABL1 on amplified episomes in T-cell acute lymphoblastic leukemia. Nat Genet 2004; 36: 1084\u20131089.", "journal-title": "Nat Genet"}, {"key": "BF2403835_CR14", "doi-asserted-by": "publisher", "first-page": "1687", "DOI": "10.1128/MCB.12.4.1687", "volume": "12", "author": "M von Lindern", "year": "1992", "unstructured": "von Lindern M, Fornerod M, van Baal S, Jaegle M, de Wit T, Buijs A et al. The translocation (6;9), associated with a specific subtype of acute myeloid leukemia, results in the fusion of two genes, dek and can, and the expression of a chimeric, leukemia-specific dek-can mRNA. Mol Cell Biol 1992; 12: 1687\u20131697.", "journal-title": "Mol Cell Biol"}, {"key": "BF2403835_CR15", "first-page": "139", "volume": "82", "author": "U Jaeger", "year": "2003", "unstructured": "Jaeger U, Kainz B . Monitoring minimal residual disease in AML: the right time for real time. Ann Hematol 2003; 82: 139\u2013147.", "journal-title": "Ann Hematol"}, {"key": "BF2403835_CR16", "doi-asserted-by": "publisher", "first-page": "578", "DOI": "10.1046/j.1365-2141.1999.01522.x", "volume": "106", "author": "JA Yin", "year": "1999", "unstructured": "Yin JA, Tobal K . Detection of minimal residual disease in acute myeloid leukaemia: methodologies, clinical and biological significance. Br J Haematol 1999; 106: 578\u2013590.", "journal-title": "Br J Haematol"}, {"key": "BF2403835_CR17", "doi-asserted-by": "publisher", "first-page": "2746", "DOI": "10.1182/blood-2003-03-0880", "volume": "102", "author": "S Schnittger", "year": "2003", "unstructured": "Schnittger S, Weisser M, Schoch C, Hiddemann W, Haferlach T, Kern W . New score predicting for prognosis in PML-RARA+, AML1-ETO+, or CBFBMYH11+ acute myeloid leukemia based on quantification of fusion transcripts. Blood 2003; 102: 2746\u20132755.", "journal-title": "Blood"}, {"key": "BF2403835_CR18", "doi-asserted-by": "publisher", "first-page": "299", "DOI": "10.1038/sj.leu.2400554", "volume": "11", "author": "J Boer", "year": "1997", "unstructured": "Boer J, Mahmoud H, Raimondi S, Grosveld G, Krance R . Loss of the DEK-CAN fusion transcript in a child with t(6;9) acute myeloid leukemia following chemotherapy and allogeneic bone marrow transplantation. Leukemia 1997; 11: 299\u2013300.", "journal-title": "Leukemia"}, {"key": "BF2403835_CR19", "doi-asserted-by": "publisher", "first-page": "139", "DOI": "10.1159/000203996", "volume": "94", "author": "H Nakano", "year": "1995", "unstructured": "Nakano H, Shimamoto Y, Suga K, Kobayashi M . Detection of minimal residual disease in a patient with acute myeloid leukemia and t(6;9) at the time of peripheral blood stem cell transplantation. Acta Haematol 1995; 94: 139\u2013141.", "journal-title": "Acta Haematol"}, {"key": "BF2403835_CR20", "doi-asserted-by": "publisher", "first-page": "522", "DOI": "10.1007/BF02986623", "volume": "77", "author": "T Maeda", "year": "2003", "unstructured": "Maeda T, Kosugi S, Ujiie H, Osumi K, Fukui T, Yoshida H et al. Localized relapse in bone marrow in a posttransplantation patient with t(6;9) acute myeloid leukemia. Int J Hematol 2003; 77: 522\u2013525.", "journal-title": "Int J Hematol"}, {"key": "BF2403835_CR21", "first-page": "33", "volume": "38", "author": "M Toyosawa", "year": "1997", "unstructured": "Toyosawa M, Shinohara K, Ariyoshi K, Ando T, Kobayashi M, Hikiji K . The detection of minimal residual disease by DEK/CAN chimeric m-RNA in a case of AML M2 with translocation t(6;9) (p23;q34) after chemotherapy and peripheral blood stem cell transplantation. Rinsho Ketsueki 1997; 38: 33\u201340.", "journal-title": "Rinsho Ketsueki"}, {"key": "BF2403835_CR22", "doi-asserted-by": "publisher", "first-page": "1213", "DOI": "10.1016/j.leukres.2004.03.011", "volume": "28", "author": "M Ostergaard", "year": "2004", "unstructured": "Ostergaard M, Stentoft J, Hokland P . A real-time quantitative RT-PCR assay for monitoring DEK-CAN fusion transcripts arising from translocation t(6;9) in acute myeloid leukemia. Leuk Res 2004; 28: 1213\u20131215.", "journal-title": "Leuk Res"}, {"key": "BF2403835_CR23", "first-page": "1267", "volume": "89", "author": "K Tobal", "year": "2004", "unstructured": "Tobal K, Frost L, Liu Yin JA . Quantification of DEK-CAN fusion transcript by real-time reverse transcription polymerase reaction in patients with t(6;9) acute myeloid leukemia. Haematologica 2004; 89: 1267\u20131269.", "journal-title": "Haematologica"}, {"key": "BF2403835_CR24", "doi-asserted-by": "publisher", "first-page": "2474", "DOI": "10.1038/sj.leu.2403136", "volume": "17", "author": "E Beillard", "year": "2003", "unstructured": "Beillard E, Pallisgaard N, van der Velden VH, Bi W, Dee R, van der Schoot E et al. Evaluation of candidate control genes for diagnosis and residual disease detection in leukemic patients using \u2018real-time\u2019 quantitative reverse-transcriptase polymerase chain reaction (RQ-PCR)\u2014a Europe against cancer program. Leukemia 2003; 17: 2474\u20132486.", "journal-title": "Leukemia"}, {"key": "BF2403835_CR25", "doi-asserted-by": "publisher", "first-page": "2318", "DOI": "10.1038/sj.leu.2403135", "volume": "17", "author": "J Gabert", "year": "2003", "unstructured": "Gabert J, Beillard E, van der Velden VH, Bi W, Grimwade D, Pallisgaard N et al. Standardization and quality control studies of \u2018real-time\u2019 quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia\u2014a Europe Against Cancer program. Leukemia 2003; 17: 2318\u20132357.", "journal-title": "Leukemia"}, {"key": "BF2403835_CR26", "doi-asserted-by": "publisher", "first-page": "2198", "DOI": "10.1182/blood-2003-01-0162", "volume": "102", "author": "M Libura", "year": "2003", "unstructured": "Libura M, Asnafi V, Tu A, Delabesse E, Tigaud I, Cymbalista F et al. FLT3 and MLL intragenic abnormalities in AML reflect a common category of genotoxic stress. Blood 2003; 102: 2198\u20132204.", "journal-title": "Blood"}, {"key": "BF2403835_CR27", "doi-asserted-by": "publisher", "first-page": "4326", "DOI": "10.1182/blood.V99.12.4326", "volume": "99", "author": "C Thiede", "year": "2002", "unstructured": "Thiede C, Steudel C, Mohr B, Schaich M, Schakel U, Platzbecker U et al. Analysis of FLT3-activating mutations in 979 patients with acute myelogenous leukemia: association with FAB subtypes and identification of subgroups with poor prognosis. Blood 2002; 99: 4326\u20134335.", "journal-title": "Blood"}, {"key": "BF2403835_CR28", "doi-asserted-by": "publisher", "first-page": "393", "DOI": "10.1002/ajh.2830180409", "volume": "18", "author": "MG Pearson", "year": "1985", "unstructured": "Pearson MG, Vardiman JW, Le Beau MM, Rowley JD, Schwartz S, Kerman SL et al. Increased numbers of marrow basophils may be associated with a t(6;9) in ANLL. Am J Hematol 1985; 18: 393\u2013403.", "journal-title": "Am J Hematol"}, {"key": "BF2403835_CR29", "doi-asserted-by": "publisher", "first-page": "209", "DOI": "10.1016/0165-4608(89)90089-7", "volume": "42", "author": "A Cuneo", "year": "1989", "unstructured": "Cuneo A, Kerim S, Vandenberghe E, Van Orshoven A, Rodhain J, Bosly A et al. Translocation t(6;9) occurring in acute myelofibrosis, myelodysplastic syndrome, and acute nonlymphocytic leukemia suggests multipotent stem cell involvement. Cancer Genet Cytogenet 1989; 42: 209\u2013219.", "journal-title": "Cancer Genet Cytogenet"}, {"key": "BF2403835_CR30", "doi-asserted-by": "publisher", "first-page": "4325", "DOI": "10.1182/blood-2002-03-0772", "volume": "100", "author": "JC Byrd", "year": "2002", "unstructured": "Byrd JC, Mrozek K, Dodge RK, Carroll AJ, Edwards CG, Arthur DC et al. Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461). Blood 2002; 100: 4325\u20134336.", "journal-title": "Blood"}, {"key": "BF2403835_CR31", "first-page": "4075", "volume": "96", "author": "ML Slovak", "year": "2000", "unstructured": "Slovak ML, Kopecky KJ, Cassileth PA, Harrington DH, Theil KS, Mohamed A et al. Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group/Eastern Cooperative Oncology Group Study. Blood 2000; 96: 4075\u20134083.", "journal-title": "Blood"}, {"key": "BF2403835_CR32", "doi-asserted-by": "publisher", "first-page": "2521", "DOI": "10.1182/blood-2002-05-1357", "volume": "101", "author": "RE Gallagher", "year": "2003", "unstructured": "Gallagher RE, Yeap BY, Bi W, Livak KJ, Beaubier N, Rao S et al. Quantitative real-time RT-PCR analysis of PML-RAR alpha mRNA in acute promyelocytic leukemia: assessment of prognostic significance in adult patients from intergroup protocol 0129. Blood 2003; 101: 2521\u20132528.", "journal-title": "Blood"}, {"key": "BF2403835_CR33", "first-page": "815", "volume": "95", "author": "K Tobal", "year": "2000", "unstructured": "Tobal K, Newton J, Macheta M, Chang J, Morgenstern G, Evans PA et al. Molecular quantitation of minimal residual disease in acute myeloid leukemia with t(8;21) can identify patients in durable remission and predict clinical relapse. Blood 2000; 95: 815\u2013819.", "journal-title": "Blood"}, {"key": "BF2403835_CR34", "doi-asserted-by": "publisher", "first-page": "788", "DOI": "10.1200/JCO.2000.18.4.788", "volume": "18", "author": "F Morschhauser", "year": "2000", "unstructured": "Morschhauser F, Cayuela JM, Martini S, Baruchel A, Rousselot P, Socie G et al. Evaluation of minimal residual disease using reverse-transcription polymerase chain reaction in t(8;21) acute myeloid leukemia: a multicenter study of 51 patients. J Clin Oncol 2000; 18: 788\u2013794.", "journal-title": "J Clin Oncol"}, {"key": "BF2403835_CR35", "first-page": "925", "volume": "93", "author": "H Ohminami", "year": "1999", "unstructured": "Ohminami H, Yasukawa M, Kaneko S, Yakushijin Y, Abe Y, Kasahara Y et al. Fas-independent and nonapoptotic cytotoxicity mediated by a human CD4(+) T-cell clone directed against an acute myelogenous leukemia-associated DEK-CAN fusion peptide. Blood 1999; 93: 925\u2013935.", "journal-title": "Blood"}, {"key": "BF2403835_CR36", "doi-asserted-by": "publisher", "first-page": "2400", "DOI": "10.1038/sj.leu.2402742", "volume": "16", "author": "M Makita", "year": "2002", "unstructured": "Makita M, Azuma T, Hamaguchi H, Niiya H, Kojima K, Fujita S et al. Leukemia-associated fusion proteins, dek-can and bcr-abl, represent immunogenic HLA-DR-restricted epitopes recognized by fusion peptide-specific CD4+ T lymphocytes. Leukemia 2002; 16: 2400\u20132407.", "journal-title": "Leukemia"}], "container-title": ["Leukemia"], "language": "en", "link": [{"URL": "http://www.nature.com/articles/2403835.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/2403835", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/2403835.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 3, 18]], "date-time": "2019-03-18T03:37:38Z", "timestamp": 1552880258000}, "score": 45.344505, "issued": {"date-parts": [[2005, 6, 23]]}, "references-count": 36, "journal-issue": {"published-print": {"date-parts": [[2005, 8]]}, "issue": "8"}, "alternative-id": ["BF2403835"], "URL": "http://dx.doi.org/10.1038/sj.leu.2403835", "relation": {"cites": []}, "ISSN": ["0887-6924", "1476-5551"], "issn-type": [{"value": "0887-6924", "type": "print"}, {"value": "1476-5551", "type": "electronic"}], "subject": ["Anesthesiology and Pain Medicine", "Cancer Research", "Hematology"]}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T02:40:00Z", "timestamp": 1574476800976}, "reference-count": 0, "publisher": "InTech", "isbn-type": [{"value": "9789533078861", "type": "print"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "DOI": "10.5772/27519", "type": "book-chapter", "created": {"date-parts": [[2012, 5, 17]], "date-time": "2012-05-17T18:06:16Z", "timestamp": 1337277976000}, "source": "Crossref", "is-referenced-by-count": 0, "title": ["Clinical and Biological Relevance of Gene Expression Profiling in Acute Myeloid Leukemia"], "prefix": "10.5772", "author": [{"given": "Alicja", "family": "M.", "sequence": "first", "affiliation": []}, {"given": "Myriam", "family": "Alcalay", "sequence": "additional", "affiliation": []}], "member": "3774", "published-online": {"date-parts": [[2012, 1, 5]]}, "container-title": ["Myeloid Leukemia - Clinical Diagnosis and Treatment"], "link": [{"URL": "http://www.intechopen.com/download/pdf/25661", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2016, 12, 29]], "date-time": "2016-12-29T11:07:50Z", "timestamp": 1483009670000}, "score": 42.935646, "issued": {"date-parts": [[2012, 1, 5]]}, "ISBN": ["9789533078861"], "references-count": 0, "URL": "http://dx.doi.org/10.5772/27519"}, {"indexed": {"date-parts": [[2019, 11, 24]], "date-time": "2019-11-24T08:44:08Z", "timestamp": 1574585048382}, "reference-count": 46, "publisher": "Springer Science and Business Media LLC", "issue": "8", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[2015, 2, 27]], "date-time": "2015-02-27T00:00:00Z", "timestamp": 1424995200000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": ["link.springer.com"], "crossmark-restriction": false}, "short-container-title": ["Leukemia"], "published-print": {"date-parts": [[2015, 8]]}, "DOI": "10.1038/leu.2015.52", "type": "journal-article", "created": {"date-parts": [[2015, 2, 27]], "date-time": "2015-02-27T07:44:36Z", "timestamp": 1425023076000}, "page": "1637-1647", "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy", "source": "Crossref", "is-referenced-by-count": 135, "title": ["CD33-specific chimeric antigen receptor T cells exhibit potent preclinical activity against human acute myeloid leukemia"], "prefix": "10.1038", "volume": "29", "author": [{"given": "S S", "family": "Kenderian", "sequence": "first", "affiliation": []}, {"given": "M", "family": "Ruella", "sequence": "additional", "affiliation": []}, {"given": "O", "family": "Shestova", "sequence": "additional", "affiliation": []}, {"given": "M", "family": "Klichinsky", "sequence": "additional", "affiliation": []}, {"given": "V", "family": "Aikawa", "sequence": "additional", "affiliation": []}, {"given": "J J D", "family": "Morrissette", "sequence": "additional", "affiliation": []}, {"given": "J", "family": "Scholler", "sequence": "additional", "affiliation": []}, {"given": "D", "family": "Song", "sequence": "additional", "affiliation": []}, {"given": "D L", "family": "Porter", "sequence": "additional", "affiliation": []}, {"given": "M", "family": "Carroll", "sequence": "additional", "affiliation": []}, {"given": "C H", "family": "June", "sequence": "additional", "affiliation": []}, {"given": "S", "family": "Gill", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2015, 2, 27]]}, "reference": [{"key": "BFleu201552_CR1", "doi-asserted-by": "publisher", "first-page": "9", "DOI": "10.3322/caac.21208", "volume": "64", "author": "R Siegel", "year": "2014", "unstructured": "Siegel R, Ma J, Zou Z, Jemal A . Cancer statistics, 2014. CA Cancer J Clin 2014; 64: 9\u201329.", "journal-title": "CA Cancer J Clin"}, {"key": "BFleu201552_CR2", "doi-asserted-by": "publisher", "first-page": "2720", "DOI": "10.1002/cncr.28129", "volume": "119", "author": "MS Thein", "year": "2013", "unstructured": "Thein MS, Ershler WB, Jemal A, Yates JW, Baer MR . Outcome of older patients with acute myeloid leukemia: an analysis of SEER data over 3 decades. Cancer 2013; 119: 2720\u20132727.", "journal-title": "Cancer"}, {"key": "BFleu201552_CR3", "doi-asserted-by": "publisher", "first-page": "556", "DOI": "10.1016/j.bbmt.2008.02.019", "volume": "14", "author": "M Hamadani", "year": "2008", "unstructured": "Hamadani M, Awan FT, Copelan EA . Hematopoietic stem cell transplantation in adults with acute myeloid leukemia. Biol Blood Marrow Transplant 2008; 14: 556\u2013567.", "journal-title": "Biol Blood Marrow Transplant"}, {"key": "BFleu201552_CR4", "doi-asserted-by": "publisher", "first-page": "3730", "DOI": "10.1200/JCO.2010.28.8852", "volume": "28", "author": "M Duval", "year": "2010", "unstructured": "Duval M, Klein JP, He W, Cahn JY, Cairo M, Camitta BM et al. Hematopoietic stem-cell transplantation for acute leukemia in relapse or primary induction failure. J Clin Oncol 2010; 28: 3730\u20133738.", "journal-title": "J Clin Oncol"}, {"key": "BFleu201552_CR5", "doi-asserted-by": "publisher", "first-page": "318", "DOI": "10.1002/ajh.23404", "volume": "88", "author": "EH Estey", "year": "2013", "unstructured": "Estey EH . Acute myeloid leukemia: 2013 update on risk-stratification and management. Am J Hematol 2013; 88: 318\u2013327.", "journal-title": "Am J Hematol"}, {"key": "BFleu201552_CR6", "doi-asserted-by": "publisher", "first-page": "49", "DOI": "10.1016/j.immuni.2013.07.002", "volume": "39", "author": "M Kalos", "year": "2013", "unstructured": "Kalos M, June CH . Adoptive T cell transfer for cancer immunotherapy in the era of synthetic biology. Immunity 2013; 39: 49\u201360.", "journal-title": "Immunity"}, {"key": "BFleu201552_CR7", "doi-asserted-by": "publisher", "first-page": "10024", "DOI": "10.1073/pnas.86.24.10024", "volume": "86", "author": "G Gross", "year": "1989", "unstructured": "Gross G, Waks T, Eshhar Z . Expression of immunoglobulin-T-cell receptor chimeric molecules as functional receptors with antibody-type specificity. Proc Natl Acad Sci USA 1989; 86: 10024\u201310028.", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "BFleu201552_CR8", "doi-asserted-by": "publisher", "first-page": "725", "DOI": "10.1056/NEJMoa1103849", "volume": "365", "author": "DL Porter", "year": "2011", "unstructured": "Porter DL, Levine BL, Kalos M, Bagg A, June CH . Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia. N Engl J Med 2011; 365: 725\u2013733.", "journal-title": "N Engl J Med"}, {"key": "BFleu201552_CR9", "doi-asserted-by": "publisher", "first-page": "1509", "DOI": "10.1056/NEJMoa1215134", "volume": "368", "author": "SA Grupp", "year": "2013", "unstructured": "Grupp SA, Kalos M, Barrett D, Aplenc R, Porter D, Rheingold S et al. Chimeric antigen receptor-modified T cells for acute lymphoid leukemia. N Engl J Med 2013; 368: 1509\u20131518.", "journal-title": "N Engl J Med"}, {"key": "BFleu201552_CR10", "doi-asserted-by": "publisher", "first-page": "95ra73", "DOI": "10.1126/scitranslmed.3002842", "volume": "3", "author": "M Kalos", "year": "2011", "unstructured": "Kalos M, Levine BL, Porter DL, Katz S, Grupp SA, Bagg A et al. T cells with chimeric antigen receptors have potent antitumor effects and can establish memory in patients with advanced leukemia. Sci Transl Med 2011; 3: 95ra73.", "journal-title": "Sci Transl Med"}, {"key": "BFleu201552_CR11", "doi-asserted-by": "publisher", "first-page": "2709", "DOI": "10.1182/blood-2011-10-384388", "volume": "119", "author": "JN Kochenderfer", "year": "2012", "unstructured": "Kochenderfer JN, Dudley ME, Feldman SA, Wilson WH, Spaner DE, Maric I et al. B-cell depletion and remissions of malignancy along with cytokine-associated toxicity in a clinical trial of anti-CD19 chimeric-antigen-receptor-transduced T cells. Blood 2012; 119: 2709\u20132720.", "journal-title": "Blood"}, {"key": "BFleu201552_CR12", "doi-asserted-by": "publisher", "first-page": "224ra225", "DOI": "10.1126/scitranslmed.3008226", "volume": "6", "author": "ML Davila", "year": "2014", "unstructured": "Davila ML, Riviere I, Wang X, Bartido S, Park J, Curran K et al. Efficacy and toxicity management of 19-28z CAR T cell therapy in B cell acute lymphoblastic leukemia. Sci Transl Med 2014; 6: 224ra225.", "journal-title": "Sci Transl Med"}, {"key": "BFleu201552_CR13", "doi-asserted-by": "publisher", "first-page": "540", "DOI": "10.1200/JCO.2014.56.2025", "volume": "33", "author": "JN Kochenderfer", "year": "2014", "unstructured": "Kochenderfer JN, Dudley ME, Kassim SH, Somerville RP, Carpenter RO, Stetler-Stevenson M et al. Chemotherapy-refractory diffuse large B-cell lymphoma and indolent B-cell malignancies can be effectively treated with autologous T cells expressing an anti-CD19 chimeric antigen receptor. J Clin Oncol 2014; 33: 540\u2013549.", "journal-title": "J Clin Oncol"}, {"key": "BFleu201552_CR14", "doi-asserted-by": "publisher", "first-page": "1507", "DOI": "10.1056/NEJMoa1407222", "volume": "371", "author": "SL Maude", "year": "2014", "unstructured": "Maude SL, Frey N, Shaw PA, Aplenc R, Barrett DM, Bunin NJ et al. Chimeric antigen receptor T cells for sustained remissions in leukemia. N Engl J Med 2014; 371: 1507\u20131517.", "journal-title": "N Engl J Med"}, {"key": "BFleu201552_CR15", "doi-asserted-by": "publisher", "first-page": "2965", "DOI": "10.1182/blood-2013-06-506741", "volume": "122", "author": "CR Cruz", "year": "2013", "unstructured": "Cruz CR, Micklethwaite KP, Savoldo B, Ramos CA, Lam S, Ku S et al. Infusion of donor-derived CD19-redirected virus-specific T cells for B-cell malignancies relapsed after allogeneic stem cell transplant: a phase 1 study. Blood 2013; 122: 2965\u20132973.", "journal-title": "Blood"}, {"key": "BFleu201552_CR16", "doi-asserted-by": "publisher", "first-page": "4168", "DOI": "10.1182/blood-2006-09-047399", "volume": "109", "author": "RB Walter", "year": "2007", "unstructured": "Walter RB, Gooley TA, van der Velden VH, Loken MR, van Dongen JJ, Flowers DA et al. CD33 expression and P-glycoprotein-mediated drug efflux inversely correlate and predict clinical outcome in patients with acute myeloid leukemia treated with gemtuzumab ozogamicin monotherapy. Blood 2007; 109: 4168\u20134170.", "journal-title": "Blood"}, {"key": "BFleu201552_CR17", "doi-asserted-by": "publisher", "first-page": "521", "DOI": "10.1016/0145-2126(84)90001-8", "volume": "8", "author": "JD Griffin", "year": "1984", "unstructured": "Griffin JD, Linch D, Sabbath K, Larcom P, Schlossman SF . A monoclonal antibody reactive with normal and leukemic human myeloid progenitor cells. Leuk Res 1984; 8: 521\u2013534.", "journal-title": "Leuk Res"}, {"key": "BFleu201552_CR18", "first-page": "1048", "volume": "67", "author": "PA Dinndorf", "year": "1986", "unstructured": "Dinndorf PA, Andrews RG, Benjamin D, Ridgway D, Wolff L, Bernstein ID . Expression of normal myeloid-associated antigens by acute leukemia cells. Blood 1986; 67: 1048\u20131053.", "journal-title": "Blood"}, {"key": "BFleu201552_CR19", "doi-asserted-by": "publisher", "first-page": "113", "DOI": "10.1016/j.leukres.2006.03.022", "volume": "31", "author": "M Schwonzen", "year": "2007", "unstructured": "Schwonzen M, Diehl V, Dellanna M, Staib P . Immunophenotyping of surface antigens in acute myeloid leukemia by flow cytometry after red blood cell lysis. Leuk Res 2007; 31: 113\u2013116.", "journal-title": "Leuk Res"}, {"key": "BFleu201552_CR20", "doi-asserted-by": "publisher", "first-page": "316", "DOI": "10.1309/E36008Y2H08Q1AYY", "volume": "129", "author": "JD Hoyer", "year": "2008", "unstructured": "Hoyer JD, Grogg KL, Hanson CA, Gamez JD, Dogan A . CD33 detection by immunohistochemistry in paraffin-embedded tissues: a new antibody shows excellent specificity and sensitivity for cells of myelomonocytic lineage. Am J Clin Pathol 2008; 129: 316\u2013323.", "journal-title": "Am J Clin Pathol"}, {"key": "BFleu201552_CR21", "doi-asserted-by": "publisher", "first-page": "986", "DOI": "10.1016/S1470-2045(14)70281-5", "volume": "15", "author": "RK Hills", "year": "2014", "unstructured": "Hills RK, Castaigne S, Appelbaum FR, Delaunay J, Petersdorf S, Othus M et al. Addition of gemtuzumab ozogamicin to induction chemotherapy in adult patients with acute myeloid leukaemia: a meta-analysis of individual patient data from randomised controlled trials. Lancet Oncol 2014; 15: 986\u2013996.", "journal-title": "Lancet Oncol"}, {"key": "BFleu201552_CR22", "doi-asserted-by": "publisher", "first-page": "2343", "DOI": "10.1182/blood-2013-09-529537", "volume": "123", "author": "S Gill", "year": "2014", "unstructured": "Gill S, Tasian SK, Ruella M, Shestova O, Li Y, Porter DL et al. Preclinical targeting of human acute myeloid leukemia and myeloablation using chimeric antigen receptor-modified T cells. Blood 2014; 123: 2343\u20132354.", "journal-title": "Blood"}, {"key": "BFleu201552_CR23", "doi-asserted-by": "publisher", "first-page": "1453", "DOI": "10.1038/mt.2009.83", "volume": "17", "author": "MC Milone", "year": "2009", "unstructured": "Milone MC, Fish JD, Carpenito C, Carroll RG, Binder GK, Teachey D et al. Chimeric receptors containing CD137 signal transduction domains mediate enhanced survival of T cells and increased antileukemic efficacy in vivo. Mol Ther 2009; 17: 1453\u20131464.", "journal-title": "Mol Ther"}, {"key": "BFleu201552_CR24", "doi-asserted-by": "publisher", "first-page": "717", "DOI": "10.1089/hum.2013.075", "volume": "24", "author": "DM Barrett", "year": "2013", "unstructured": "Barrett DM, Liu X, Jiang S, June CH, Grupp SA, Zhao Y . Regimen-specific effects of RNA-modified chimeric antigen receptor T cells in mice with advanced leukemia. Hum Gene Ther 2013; 24: 717\u2013727.", "journal-title": "Hum Gene Ther"}, {"key": "BFleu201552_CR25", "doi-asserted-by": "publisher", "first-page": "1575", "DOI": "10.1089/hum.2011.070", "volume": "22", "author": "DM Barrett", "year": "2011", "unstructured": "Barrett DM, Zhao Y, Liu X, Jiang S, Carpenito C, Kalos M et al. Treatment of advanced leukemia in mice with mRNA engineered T cells. Hum Gene Ther 2011; 22: 1575\u20131586.", "journal-title": "Hum Gene Ther"}, {"key": "BFleu201552_CR26", "doi-asserted-by": "publisher", "first-page": "151", "DOI": "10.1016/j.ymthe.2005.07.688", "volume": "13", "author": "Y Zhao", "year": "2006", "unstructured": "Zhao Y, Zheng Z, Cohen CJ, Gattinoni L, Palmer DC, Restifo NP et al. High-efficiency transfection of primary human and mouse T lymphocytes using RNA electroporation. Mol Ther 2006; 13: 151\u2013159.", "journal-title": "Mol Ther"}, {"key": "BFleu201552_CR27", "doi-asserted-by": "publisher", "first-page": "497", "DOI": "10.1016/S0091-679X(04)75020-7", "volume": "75", "author": "MR Betts", "year": "2004", "unstructured": "Betts MR, Koup RA . Detection of T-cell degranulation: CD107a and b. Methods Cell Biol 2004; 75: 497\u2013512.", "journal-title": "Methods Cell Biol"}, {"key": "BFleu201552_CR28", "doi-asserted-by": "publisher", "first-page": "534", "DOI": "10.1002/cyto.a.20887", "volume": "77", "author": "LF Cao", "year": "2010", "unstructured": "Cao LF, Krymskaya L, Tran V, Mi S, Jensen MC, Blanchard S et al. Development and application of a multiplexable flow cytometry-based assay to quantify cell-mediated cytolysis. Cytometry A 2010; 77: 534\u2013545.", "journal-title": "Cytometry A"}, {"key": "BFleu201552_CR29", "doi-asserted-by": "publisher", "first-page": "3705", "DOI": "10.1182/blood-2011-12-398370", "volume": "119", "author": "JA Pollard", "year": "2012", "unstructured": "Pollard JA, Alonzo TA, Loken M, Gerbing RB, Ho PA, Bernstein ID et al. Correlation of CD33 expression level with disease characteristics and response to gemtuzumab ozogamicin containing chemotherapy in childhood AML. Blood 2012; 119: 3705\u20133711.", "journal-title": "Blood"}, {"key": "BFleu201552_CR30", "doi-asserted-by": "publisher", "first-page": "1295", "DOI": "10.1182/blood-2004-07-2784", "volume": "105", "author": "RB Walter", "year": "2005", "unstructured": "Walter RB, Raden BW, Kamikura DM, Cooper JA, Bernstein ID . Influence of CD33 expression levels and ITIM-dependent internalization on gemtuzumab ozogamicin-induced cytotoxicity. Blood 2005; 105: 1295\u20131302.", "journal-title": "Blood"}, {"key": "BFleu201552_CR31", "doi-asserted-by": "publisher", "first-page": "e218", "DOI": "10.1038/bcj.2014.39", "volume": "4", "author": "A Ehninger", "year": "2014", "unstructured": "Ehninger A, Kramer M, Rollig C, Thiede C, Bornhauser M, von Bonin M et al. Distribution and levels of cell surface expression of CD33 and CD123 in acute myeloid leukemia. Blood Cancer J 2014; 4: e218.", "journal-title": "Blood Cancer J"}, {"key": "BFleu201552_CR32", "doi-asserted-by": "publisher", "first-page": "3360", "DOI": "10.1073/pnas.0813101106", "volume": "106", "author": "C Carpenito", "year": "2009", "unstructured": "Carpenito C, Milone MC, Hassan R, Simonet JC, Lakhal M, Suhoski MM et al. Control of large, established tumor xenografts with genetically retargeted human T cells containing CD28 and CD137 domains. Proc Natl Acad Sci USA 2009; 106: 3360\u20133365.", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "BFleu201552_CR33", "doi-asserted-by": "publisher", "first-page": "1785", "DOI": "10.1038/leu.2010.158", "volume": "24", "author": "M Wunderlich", "year": "2010", "unstructured": "Wunderlich M, Chou FS, Link KA, Mizukawa B, Perry RL, Carroll M et al. AML xenograft efficiency is significantly improved in NOD/SCID-IL2RG mice constitutively expressing human SCF, GM-CSF and IL-3. Leukemia 2010; 24: 1785\u20131788.", "journal-title": "Leukemia"}, {"key": "BFleu201552_CR34", "doi-asserted-by": "publisher", "first-page": "3461", "DOI": "10.1182/blood-2013-04-493361", "volume": "122", "author": "M Casucci", "year": "2013", "unstructured": "Casucci M, Nicolis di Robilant B, Falcone L, Camisa B, Norelli M, Genovese P et al. CD44v6-targeted T cells mediate potent antitumor effects against acute myeloid leukemia and multiple myeloma. Blood 2013; 122: 3461\u20133472.", "journal-title": "Blood"}, {"key": "BFleu201552_CR35", "doi-asserted-by": "publisher", "first-page": "3138", "DOI": "10.1182/blood-2012-12-474056", "volume": "122", "author": "A Mardiros", "year": "2013", "unstructured": "Mardiros A, Dos Santos C, McDonald T, Brown CE, Wang X, Budde LE et al. T cells expressing CD123-specific chimeric antigen receptors exhibit specific cytolytic effector functions and antitumor effects against human acute myeloid leukemia. Blood 2013; 122: 3138\u20133148.", "journal-title": "Blood"}, {"key": "BFleu201552_CR36", "doi-asserted-by": "publisher", "first-page": "1596", "DOI": "10.1038/leu.2014.62", "volume": "28", "author": "I Pizzitola", "year": "2014", "unstructured": "Pizzitola I, Anjos-Afonso F, Rouault-Pierre K, Lassailly F, Tettamanti S, Spinelli O et al. Chimeric antigen receptors against CD33/CD123 antigens efficiently target primary acute myeloid leukemia cells in vivo. Leukemia 2014; 28: 1596\u20131605.", "journal-title": "Leukemia"}, {"key": "BFleu201552_CR37", "doi-asserted-by": "publisher", "first-page": "683065", "DOI": "10.1155/2012/683065", "volume": "2012", "author": "A Dutour", "year": "2012", "unstructured": "Dutour A, Marin V, Pizzitola I, Valsesia-Wittmann S, Lee D, Yvon E et al. In vitro and in vivo antitumor effect of anti-CD33 chimeric receptor-expressing EBV-CTL against CD33 acute myeloid leukemia. Adv Hematol 2012; 2012: 683065.", "journal-title": "Adv Hematol"}, {"key": "BFleu201552_CR38", "doi-asserted-by": "publisher", "first-page": "125", "DOI": "10.1158/2326-6066.CIR-14-0127", "volume": "3", "author": "M Hudecek", "year": "2014", "unstructured": "Hudecek M, Sommermeyer D, Kosasih PL, Silva-Benedict A, Liu L, Rader C et al. The non-signaling extracellular spacer domain of chimeric antigen receptors is decisive for in vivo antitumor activity. Cancer Immunol Res 2014; 3: 125\u2013135.", "journal-title": "Cancer Immunol Res"}, {"key": "BFleu201552_CR39", "doi-asserted-by": "publisher", "first-page": "1165", "DOI": "10.1182/blood-2012-06-438002", "volume": "121", "author": "W Haso", "year": "2013", "unstructured": "Haso W, Lee DW, Shah NN, Stetler-Stevenson M, Yuan CM, Pastan IH et al. Anti-CD22-chimeric antigen receptors targeting B-cell precursor acute lymphoblastic leukemia. Blood 2013; 121: 1165\u20131174.", "journal-title": "Blood"}, {"key": "BFleu201552_CR40", "doi-asserted-by": "publisher", "first-page": "1442", "DOI": "10.1002/cncr.21326", "volume": "104", "author": "RA Larson", "year": "2005", "unstructured": "Larson RA, Sievers EL, Stadtmauer EA, Lowenberg B, Estey EH, Dombret H et al. Final report of the efficacy and safety of gemtuzumab ozogamicin (Mylotarg) in patients with CD33-positive acute myeloid leukemia in first recurrence. Cancer 2005; 104: 1442\u20131452.", "journal-title": "Cancer"}, {"key": "BFleu201552_CR41", "doi-asserted-by": "publisher", "first-page": "2728", "DOI": "10.1002/cncr.28136", "volume": "119", "author": "H Kantarjian", "year": "2013", "unstructured": "Kantarjian H, Thomas D, Jorgensen J, Kebriaei P, Jabbour E, Rytting M et al. Results of inotuzumab ozogamicin, a CD22 monoclonal antibody, in refractory and relapsed acute lymphocytic leukemia. Cancer 2013; 119: 2728\u20132736.", "journal-title": "Cancer"}, {"key": "BFleu201552_CR42", "doi-asserted-by": "publisher", "first-page": "403", "DOI": "10.1016/S1470-2045(11)70386-2", "volume": "13", "author": "H Kantarjian", "year": "2012", "unstructured": "Kantarjian H, Thomas D, Jorgensen J, Jabbour E, Kebriaei P, Rytting M et al. Inotuzumab ozogamicin, an anti-CD22-calecheamicin conjugate, for refractory and relapsed acute lymphocytic leukaemia: a phase 2 study. Lancet Oncol 2012; 13: 403\u2013411.", "journal-title": "Lancet Oncol"}, {"key": "BFleu201552_CR43", "doi-asserted-by": "publisher", "first-page": "2122", "DOI": "10.1038/mt.2013.154", "volume": "21", "author": "DS Ritchie", "year": "2013", "unstructured": "Ritchie DS, Neeson PJ, Khot A, Peinert S, Tai T, Tainton K et al. Persistence and efficacy of second generation CAR-T cell against the LeY antigen in acute myeloid leukemia. Mol Ther 2013; 21: 2122\u20132129.", "journal-title": "Mol Ther"}, {"key": "BFleu201552_CR44", "doi-asserted-by": "publisher", "first-page": "184", "DOI": "10.1038/mt.2014.164", "volume": "23", "author": "QS Wang", "year": "2014", "unstructured": "Wang QS, Wang Y, Lv HY, Han QW, Fan H, Guo B et al. Treatment of CD33-directed chimeric antigen receptor-modified T cells in one patient with relapsed and refractory acute myeloid leukemia. Mol Ther 2014; 23: 184\u2013191.", "journal-title": "Mol Ther"}, {"key": "BFleu201552_CR45", "doi-asserted-by": "publisher", "first-page": "112", "DOI": "10.1158/2326-6066.CIR-13-0170", "volume": "2", "author": "GL Beatty", "year": "2014", "unstructured": "Beatty GL, Haas AR, Maus MV, Torigian DA, Soulen MC, Plesa G et al. Mesothelin-specific chimeric antigen receptor mRNA-engineered T cells induce anti-tumor activity in solid malignancies. Cancer Immunol Res 2014; 2: 112\u2013120.", "journal-title": "Cancer Immunol Res"}, {"key": "BFleu201552_CR46", "doi-asserted-by": "publisher", "first-page": "1248", "DOI": "10.1038/sj.mt.6300190", "volume": "15", "author": "C Bonini", "year": "2007", "unstructured": "Bonini C, Bondanza A, Perna SK, Kaneko S, Traversari C, Ciceri F et al. The suicide gene therapy challenge: how to improve a successful gene therapy approach. Mol Ther 2007; 15: 1248\u20131252.", "journal-title": "Mol Ther"}], "container-title": ["Leukemia"], "language": "en", "link": [{"URL": "http://www.nature.com/articles/leu201552.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/leu201552", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/leu201552.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 4, 19]], "date-time": "2019-04-19T17:13:31Z", "timestamp": 1555694011000}, "score": 42.31557, "issued": {"date-parts": [[2015, 2, 27]]}, "references-count": 46, "journal-issue": {"published-print": {"date-parts": [[2015, 8]]}, "issue": "8"}, "alternative-id": ["BFleu201552"], "URL": "http://dx.doi.org/10.1038/leu.2015.52", "relation": {"cites": []}, "ISSN": ["0887-6924", "1476-5551"], "issn-type": [{"value": "0887-6924", "type": "print"}, {"value": "1476-5551", "type": "electronic"}], "assertion": [{"value": "30 October 2014", "order": 1, "name": "received", "label": "Received", "group": {"name": "ArticleHistory", "label": "Article History"}}, {"value": "5 February 2015", "order": 2, "name": "revised", "label": "Revised", "group": {"name": "ArticleHistory", "label": "Article History"}}, {"value": "19 February 2015", "order": 3, "name": "accepted", "label": "Accepted", "group": {"name": "ArticleHistory", "label": "Article History"}}, {"value": "27 February 2015", "order": 4, "name": "first_online", "label": "First Online", "group": {"name": "ArticleHistory", "label": "Article History"}}, {"value": "CHJ and DLP have filed patent applications related to CAR technology and could potentially receive licensing royalties from Novartis corporation. The other authors declare no conflict of interest.", "order": 1, "name": "Ethics", "group": {"name": "EthicsHeading", "label": "Competing interests"}}]}, {"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T06:56:36Z", "timestamp": 1574146596274}, "reference-count": 32, "publisher": "Springer Science and Business Media LLC", "issue": "57", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[2002, 12, 1]], "date-time": "2002-12-01T00:00:00Z", "timestamp": 1038700800000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Oncogene"], "published-print": {"date-parts": [[2002, 12]]}, "DOI": "10.1038/sj.onc.1206041", "type": "journal-article", "created": {"date-parts": [[2002, 12, 17]], "date-time": "2002-12-17T11:56:40Z", "timestamp": 1040126200000}, "page": "8862-8870", "source": "Crossref", "is-referenced-by-count": 23, "title": ["YY1 and NF-Y binding sites regulate the transcriptional activity of the dek and dek-can promoter"], "prefix": "10.1038", "volume": "21", "author": [{"given": "Kajal V", "family": "Sitwala", "sequence": "first", "affiliation": []}, {"given": "Kristine", "family": "Adams", "sequence": "additional", "affiliation": []}, {"given": "David M", "family": "Markovitz", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2002, 12, 16]]}, "reference": [{"key": "BF1206041_CR1", "unstructured": "Alexiadis V, Waldmann T, Andersen J, Mann M, Knippers R, Gruss C . 2000 Genes Dev. 14: 1308\u20131312"}, {"key": "BF1206041_CR2", "unstructured": "Aravind L, Koonin E . 2000 Trends Biochem. Sci. 25: 112\u2013114"}, {"key": "BF1206041_CR3", "unstructured": "Arnaudo J, Deibener J, Kaminsky P . 1998 J. Rheumatol. 25: 1861\u20131862"}, {"key": "BF1206041_CR4", "unstructured": "Dignam J, Lebovitz R, Roeder R . 1983 Nucleic Acids Res. 11: 1475\u20131489"}, {"key": "BF1206041_CR5", "unstructured": "Dong X, Wang J, Kabir F, Shaw M, Reed A, Stein L, Andrade L, Trevisani V, Miller M, Fujii T, Akizuki M, Pachman L, Satoh M, Reeves W . 2000 Arthritis Rheum. 43: 85\u201393"}, {"key": "BF1206041_CR6", "unstructured": "Donohoe M, Zhang X, McGinnis L, Biggers J, Li E, Shi Y . 1999 Mol. Cell. Biol. 19: 7237\u20137244"}, {"key": "BF1206041_CR7", "unstructured": "Duan Z, Stamatoyannopoulos G, Li Q . 2001 Mol. Cell. Biol. 21: 3083\u20133095"}, {"key": "BF1206041_CR8", "unstructured": "Faulkner N, Hilfinger J, Markovitz D . 2001 J. Biol. Chem. 276: 25804\u201325812"}, {"key": "BF1206041_CR9", "unstructured": "Flanagan J . 1995 Cell Growth Differ. 6: 185\u2013190"}, {"key": "BF1206041_CR10", "unstructured": "Fornerod M, Boer J, van Baal S, Jaegle M, von Lindern M, Murti K, Davis D, Bonten J, Buijs A, Grosveld G . 1995 Oncogene 10: 1739\u20131748"}, {"key": "BF1206041_CR11", "unstructured": "Fu G, Grosveld G, Markovitz D . 1997 Proc. Natl. Acad. Sci. USA 94: 1811\u20131815", "DOI": "10.1073/pnas.94.5.1811", "doi-asserted-by": "crossref"}, {"key": "BF1206041_CR12", "unstructured": "Grottke C, Mantwill K, Dietal M, Schadendorf D, Lage H . 2000 Int. J. Cancer 88: 535\u2013546"}, {"key": "BF1206041_CR13", "unstructured": "Heinemeyer T, Wingender E, Reuter I, Hermjakob H, Kel A, Kel O, Ignatieva E, Ananko E, Podkolodnaya O, Kolpakov F, Podkolodny N, Kolchanov N . 1998 Nucleic Acids Res. 26: 362\u2013367"}, {"key": "BF1206041_CR14", "unstructured": "Hu Q, Maity S . 2000 J. Biol. Chem. 275: 4435\u20134444"}, {"key": "BF1206041_CR15", "unstructured": "Kondoh N, Wakatsuki T, Ryo A, Hada A, Aihara T, Horiuchi S, Goseki N, Matsubara O, Takenaka K, Shichita M, Tanaka K, Shuda M, Yamamoto M . 1999 Cancer Res. 59: 4990\u20134996"}, {"key": "BF1206041_CR16", "unstructured": "Kroes R, Jastrow A, McLone M, Yamamoto H, Colley P, Kersey D, Yong V, Mkrdichian E, Cerullo L, Leestma J, Moskal J . 2000 Cancer Lett. 156: 191\u2013198"}, {"key": "BF1206041_CR17", "unstructured": "Le Hir H, Izaurralde E, Maquat L, Moore M . 2000 EMBO J. 19: 6860\u20136869"}, {"key": "BF1206041_CR18", "unstructured": "Le Hir H, Gatfield D, Izaurralde E, Moore M . 2001 EMBO J. 20: 4987\u20134997"}, {"key": "BF1206041_CR19", "unstructured": "Li X, Hooft van Huijsduijnen R, Mantovani R, Benoist C, Mathis D . 1992 J. Biol. Chem. 267: 8984\u20138990"}, {"key": "BF1206041_CR20", "unstructured": "Mantovani R . 1998 Nucleic Acids Res. 26: 1135\u20131143"}, {"key": "BF1206041_CR21", "unstructured": "Mantovani R . 1999 Gene 239: 15\u201327"}, {"key": "BF1206041_CR22", "unstructured": "McGarvey T, Rosonina E, McCracken S, Li Q, Arnaout R, Mientjes E, Nickerson J, Awre D, Greenblatt J, Grosveld G, Blencowe B . 2000 J. Cell Biol. 150: 309\u2013320"}, {"key": "BF1206041_CR23", "unstructured": "Meyn M, Lu-Kuo J, Herzing L . 1993 Am. J. Hum. Genet. 53: 1206\u20131216"}, {"key": "BF1206041_CR24", "unstructured": "Minuzzo M, Marchina S, Broggini M, Faircloth G, d'Incalci M, Mantovani R . 2000 Proc. Natl. Acad. Sci. USA 97: 6780\u20136784"}, {"key": "BF1206041_CR25", "unstructured": "Murray K, Szer W, Grom A, Donnelly P, Levinson J, Giannini E, Glass D, Szer I . 1997 J. Rheumatol. 24: 560\u2013567"}, {"key": "BF1206041_CR26", "unstructured": "Petkova V, Romanowski M, Sulijoadikusumo I, Rohne D, Kang P, Shenk T, Usheva A . 2001 J. Biol. Chem. 276: 7932\u20137936"}, {"key": "BF1206041_CR27", "unstructured": "Shi Y, Lee J, Galvin K . 1997 Biochim. Biophys. Acta 1332: F49\u2013F66"}, {"key": "BF1206041_CR28", "unstructured": "Shrivastava A, Calame K . 1994 Nucleic Acids Res. 22: 5151\u20135155"}, {"key": "BF1206041_CR29", "unstructured": "Sierakowska H, Williams K, Szer I, Szer W . 1993 Clin. Exp. Immunol. 94: 435\u2013439"}, {"key": "BF1206041_CR30", "unstructured": "Tanaka H, Ohshima N, Hidaka H . 1999 Mol. Pharmacol. 55: 356\u2013363"}, {"key": "BF1206041_CR31", "unstructured": "von Lindern M, Fornerod M, van Baal S, Jaegle M, de Wit T, Buijs A, Grosveld G . 1992 Mol. Cell. Biol. 12: 1687\u20131697", "DOI": "10.1128/MCB.12.4.1687", "doi-asserted-by": "crossref"}, {"key": "BF1206041_CR32", "unstructured": "Zhou Y, Lee A . 1998 J. Natl. Cancer Inst. 90: 381\u2013388"}], "container-title": ["Oncogene"], "language": "en", "link": [{"URL": "http://www.nature.com/articles/1206041.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/1206041", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/1206041.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 3, 15]], "date-time": "2019-03-15T20:43:30Z", "timestamp": 1552682610000}, "score": 42.233566, "issued": {"date-parts": [[2002, 12]]}, "references-count": 32, "journal-issue": {"published-print": {"date-parts": [[2002, 12]]}, "issue": "57"}, "alternative-id": ["BF1206041"], "URL": "http://dx.doi.org/10.1038/sj.onc.1206041", "relation": {"cites": []}, "ISSN": ["0950-9232", "1476-5594"], "issn-type": [{"value": "0950-9232", "type": "print"}, {"value": "1476-5594", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 21]], "date-time": "2019-11-21T11:56:15Z", "timestamp": 1574337375416}, "reference-count": 16, "publisher": "Informa UK Limited", "issue": "12", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Leukemia & Lymphoma"], "published-print": {"date-parts": [[2007, 1]]}, "DOI": "10.1080/10428190701671036", "type": "journal-article", "created": {"date-parts": [[2007, 12, 8]], "date-time": "2007-12-08T06:17:04Z", "timestamp": 1197094624000}, "page": "2418-2423", "source": "Crossref", "is-referenced-by-count": 1, "title": ["Specific pattern of protein expression in acute myeloid leukemia harboring FLT3-ITD mutations"], "prefix": "10.1080", "volume": "48", "author": [{"given": "Sebastian", "family": "Scholl", "sequence": "first", "affiliation": []}, {"given": "Christian", "family": "Melle", "sequence": "additional", "affiliation": []}, {"given": "Annett", "family": "Bleul", "sequence": "additional", "affiliation": []}, {"given": "Baerbel", "family": "Spies-Weisshart", "sequence": "additional", "affiliation": []}, {"given": "Christa", "family": "Kunert", "sequence": "additional", "affiliation": []}, {"given": "Klaus", "family": "H\u00f6ffken", "sequence": "additional", "affiliation": []}, {"given": "Ferdinand", "family": "von Eggeling", "sequence": "additional", "affiliation": []}], "member": "301", "published-online": {"date-parts": [[2009, 7]]}, "reference": [{"key": "CIT0001", "DOI": "10.1016/S0268-960X(03)00040-7", "doi-asserted-by": "publisher"}, {"key": "CIT0002", "DOI": "10.1056/NEJMoa041974", "doi-asserted-by": "publisher"}, {"key": "CIT0003", "author": "Nakao M", "volume": "10", "first-page": "1911", "year": "1996", "journal-title": "Leukemia"}, {"key": "CIT0004", "DOI": "10.1182/blood-2005-06-2248", "doi-asserted-by": "publisher"}, {"key": "CIT0005", "DOI": "10.1182/blood-2005-05-2164", "doi-asserted-by": "publisher"}, {"key": "CIT0006", "DOI": "10.1182/blood.V98.6.1752", "doi-asserted-by": "publisher"}, {"key": "CIT0007", "DOI": "10.1182/blood.V99.12.4326", "doi-asserted-by": "publisher"}, {"key": "CIT0008", "DOI": "10.1038/sj.onc.1205332", "doi-asserted-by": "publisher"}, {"key": "CIT0009", "DOI": "10.1182/blood.V97.8.2434", "doi-asserted-by": "publisher"}, {"key": "CIT0010", "DOI": "10.1046/j.1365-2141.2001.02850.x", "doi-asserted-by": "publisher"}, {"key": "CIT0011", "DOI": "10.1182/blood-2002-05-1440", "doi-asserted-by": "publisher"}, {"key": "CIT0012", "DOI": "10.1158/1078-0432.CCR-04-0307", "doi-asserted-by": "publisher"}, {"key": "CIT0013", "DOI": "10.1038/sj.onc.1209689", "doi-asserted-by": "publisher"}, {"key": "CIT0014", "DOI": "10.1016/j.lab.2005.03.005", "doi-asserted-by": "publisher"}, {"key": "CIT0015", "DOI": "10.1182/blood-2004-11-4430", "doi-asserted-by": "publisher"}, {"key": "CIT0016", "DOI": "10.1182/blood-2002-06-1677", "doi-asserted-by": "publisher"}], "container-title": ["Leukemia & Lymphoma"], "language": "en", "link": [{"URL": "http://www.tandfonline.com/doi/pdf/10.1080/10428190701671036", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2016, 12, 15]], "date-time": "2016-12-15T15:51:39Z", "timestamp": 1481817099000}, "score": 41.99177, "issued": {"date-parts": [[2007, 1]]}, "references-count": 16, "journal-issue": {"published-online": {"date-parts": [[2009, 7]]}, "published-print": {"date-parts": [[2007, 1]]}, "issue": "12"}, "alternative-id": ["10.1080/10428190701671036"], "URL": "http://dx.doi.org/10.1080/10428190701671036", "relation": {"cites": []}, "ISSN": ["1042-8194", "1029-2403"], "issn-type": [{"value": "1042-8194", "type": "print"}, {"value": "1029-2403", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 22]], "date-time": "2019-11-22T16:52:02Z", "timestamp": 1574441522082}, "publisher-location": "Berlin, Heidelberg", "reference-count": 20, "publisher": "Springer Berlin Heidelberg", "isbn-type": [{"value": "9783642639494", "type": "print"}, {"value": "9783642593581", "type": "electronic"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2003]]}, "DOI": "10.1007/978-3-642-59358-1_8", "type": "book-chapter", "created": {"date-parts": [[2012, 1, 6]], "date-time": "2012-01-06T07:51:30Z", "timestamp": 1325836290000}, "page": "28-33", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Inducible AML1/ET0 Expression in U-937 Myeloid Cells: a Model to Identify Genes Targeted by the Leukemia-Specific Fusion Protein"], "prefix": "10.1007", "author": [{"given": "M.", "family": "Fliegauf", "sequence": "first", "affiliation": []}, {"given": "J.", "family": "Burger", "sequence": "additional", "affiliation": []}, {"given": "R.", "family": "Claus", "sequence": "additional", "affiliation": []}, {"given": "M.", "family": "Stock", "sequence": "additional", "affiliation": []}, {"given": "F.", "family": "Otto", "sequence": "additional", "affiliation": []}, {"given": "M.", "family": "L\u00fcbbert", "sequence": "additional", "affiliation": []}], "member": "297", "reference": [{"key": "8_CR1", "doi-asserted-by": "publisher", "first-page": "296", "DOI": "10.1046/j.1365-2141.1999.01377.x", "volume": "106", "author": "JR Downing", "year": "1999", "unstructured": "Downing J.R. (1999). The AMLl-ETO chimaeric transcription factor in acute myeloid leukemia: biology and clinical significance. British Journal of Haema- tology 106,296\u2013308", "journal-title": "British Journal of Haematology"}, {"key": "8_CR2", "doi-asserted-by": "publisher", "first-page": "1701", "DOI": "10.1038/sj.onc.1202459", "volume": "18", "author": "RC Frank", "year": "1999", "unstructured": "Frank R.C., Sun X., Berguido F.J., Jakubowiak A. and Nimer S.D. (1999). The t(8:21) fusion protein, AMLl/ETO, transforms NIH3T3 cells and activates AP-1. Oncogene 18,1701\u20131710", "journal-title": "Oncogene"}, {"key": "8_CR3", "first-page": "1", "volume": "482", "author": "N Harakawa", "year": "1999", "unstructured": "Harakawa N. and Zhang D-R. (1999). The inducible expression of t(8;21) fusion protein AMLl-ETO leads to cell apoptosis and up-regulation of UBP43 gene expression. Blood 94 Suppl 1,482a", "journal-title": "Blood 94 Suppl"}, {"key": "8_CR4", "doi-asserted-by": "publisher", "first-page": "5640", "DOI": "10.1093/nar/22.25.5640", "volume": "22", "author": "M Hubank", "year": "1994", "unstructured": "Hubank M. and Schatz D.G. (1994). Identifying differences in mRNA expression by representational difference analysis of cDNA. Nucleic Acids Research 22,5640\u20135648", "journal-title": "Nucleic Acids Research"}, {"key": "8_CR5", "doi-asserted-by": "publisher", "first-page": "325", "DOI": "10.1016/S0076-6879(99)03021-9", "volume": "303", "author": "M Hubank", "year": "1999", "unstructured": "Hubank M. and Schatz D.G. (1999). cDNA representational difference analysis: a sensitive and flexible method for identification of differentially expressed genes. Methods in Enzymology 303,325\u2013349", "journal-title": "Methods in Enzymology"}, {"key": "8_CR6", "doi-asserted-by": "publisher", "first-page": "946", "DOI": "10.1126/science.8438152", "volume": "259", "author": "N Lisitsyn", "year": "1993", "unstructured": "Lisitsyn N., Lisitsyn N. and Wigler M., (1993). Cloning the differences between two complex genomes. Science 259,946\u2013951", "journal-title": "Science"}, {"key": "8_CR7", "doi-asserted-by": "publisher", "first-page": "291", "DOI": "10.1016/0076-6879(95)54021-0", "volume": "254", "author": "N Lisitsyn", "year": "1995", "unstructured": "Lisitsyn N, and Wigler M., (1995). Representational difference analysis in detection of genetic lesions in cancer. Methods in Enzymology 254,291\u2013304", "journal-title": "Methods in Enzymology"}, {"key": "8_CR8", "first-page": "3029", "volume": "19", "author": "LQ Liu", "year": "1999", "unstructured": "Liu L-Q., Ilaria R., Kingsley P.D., Iwama A., Van Etten R.A., Palis J., and Zhang D-E. (1999). A novel ubi- quitin-specific protease, UBP43, cloned from leukemia fusion protein AMLl-ETO-expressing mice, functions in hematopoietic cell differentiation. Mol. Cell. Biol. 19,3029\u20133038", "journal-title": "Biol"}, {"key": "8_CR9", "doi-asserted-by": "publisher", "first-page": "223", "DOI": "10.1016/S0378-1119(00)00014-7", "volume": "245", "author": "B Lutterbach", "year": "2000", "unstructured": "Lutterbach B. and Hiebert S.W. (2000). Role of the transcription factor AML-1 in acute leukemia and hematopoietic differentiation. Gene 245,223\u2013235", "journal-title": "Gene"}, {"key": "8_CR10", "doi-asserted-by": "publisher", "first-page": "3346", "DOI": "10.1073/pnas.93.8.3346", "volume": "93", "author": "D No", "year": "1996", "unstructured": "No D., Yao T-P. and Evans R.M. (1996). Ecdysone-indu- cible gene expression in mammalian cells and transgenic mice. Proc. Natl. Acad. Sci. 93,3346\u20133351", "journal-title": "Proc. Natl. Acad. Sci"}, {"key": "8_CR11", "first-page": "6336", "volume": "13", "author": "S Meyers", "year": "1993", "unstructured": "Meyers S., Downing J.R. and Hiebert S.W. (1993). Identification of AML-1 and the (8;21) translocation protein (AML-1/ETO) as sequence specific DNA- binding proteins: the runt homology domain is required for DNA binding and protein-protein interactions, Mol. Cell. Biol. 13,6336\u20136345", "journal-title": "Biol"}, {"key": "8_CR12", "first-page": "1", "volume": "86", "author": "G Nucifora", "year": "1995", "unstructured": "Nucifora G. and Rowley J.D. (1995). AMLl and the 8;21 and 3;21 translocations in acute and chronic myeloid leukemia. Blood 86,1\u201314", "journal-title": "Blood"}, {"key": "8_CR13", "doi-asserted-by": "publisher", "first-page": "314", "DOI": "10.1006/viro.1993.1262", "volume": "194", "author": "E Ogawa", "year": "1993", "unstructured": "Ogawa E., Inuzuka M., Maruyama M., Satake M., Naito-Fujimoto M., Ito Y. and Shigesada K. (1993). Molecular cloning and characterization of PEBP20, the heterodimeric partner of a novel Drosophila runt-related DNA binding protein PEBP2a. Virology 194,314\u2013331", "journal-title": "Virology"}, {"key": "8_CR14", "doi-asserted-by": "publisher", "first-page": "765", "DOI": "10.1016/S0092-8674(00)80259-7", "volume": "89", "author": "F Otto", "year": "1997", "unstructured": "Otto F., Thornell A.P., Crompton T., Denzel A., Gilmour K.C., Rosewell I.R., Stamp G.W.H., Beddington R.S.P., Mundlos S. and Owen M.J. (1997). Cbfal, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell 89,765\u2013771", "journal-title": "Cell"}, {"key": "8_CR15", "doi-asserted-by": "publisher", "first-page": "444", "DOI": "10.1038/86515", "volume": "7", "author": "T Pabst", "year": "2001", "unstructured": "Pabst T., Mueller B.U., Harakawa N., Schoch C., Haferlach T., Behre G., Hiddemann W., Zhang D-E. and Tenen D,G. (2001). AMLl-ETO downregulates the granulocytic differentiation factor C/EBPa in t(8;21) myeloid leukemia. Nature Medicine 7,444\u2013451", "journal-title": "Nature Medicine"}, {"key": "8_CR16", "doi-asserted-by": "crossref", "first-page": "129", "DOI": "10.3109/10425179309020152", "volume": "4", "author": "ML Riccio", "year": "1993", "unstructured": "Riccio M.L. and Rossolini G.M. (1993). Unusual clustering of Alu repeats within the 5\u2019-flanking region of the human lysozyme gene. DNA Sequence 4,129\u2013134", "journal-title": "DNA Sequence"}, {"key": "8_CR17", "first-page": "655", "volume": "96", "author": "H Shimada", "year": "2000", "unstructured": "Shimada H., Ichikawa H., Nakamura S., Katsu R., Iwasa M., Katabayashi I. and Ohki M. (2000). Analysis of genes under the downstream control of the t(8;21) fusion protein AML1-MTG8: overexpression of the TISllb (ERF-1, cMGl) gene induces myeloid cell proliferation in response to G-CSF. Blood 96,655\u2013663.", "journal-title": "Blood"}, {"key": "8_CR18", "first-page": "288", "volume": "96", "author": "K Shimizu", "year": "2000", "unstructured": "Shimizu K., Katabayashi I., Kamada N., Abe T. Maseki N., Suzukawa K and Ohki M. (2000). AML1-MTG8 leukemic protein induces the expression of granulocyte colony-stimulating factor (G-CSF) receptor through the up-regulation of CCAAT/enhancer binding protein epsilon. Blood 96,288\u2013296", "journal-title": "Blood"}, {"key": "8_CR19", "first-page": "1789", "volume": "59", "author": "NA Speck", "year": "1999", "unstructured": "Speck N.A., Stacy T., Wang Q., North T., Gu T-L., Miller J., Binder M. and Marin-Padilla M. (1999). Core-Bin- ding Factor: A cetral player in hematopoiesis and leukemia. Cancer Res. (Suppl.) 59,1789\u20131793", "journal-title": "(Suppl.)"}, {"key": "8_CR20", "first-page": "3324", "volume": "13", "author": "S Wang", "year": "1993", "unstructured": "Wang S., Wang Q., Crute B.E., Melnikova I.N., Keller S.R. and Speck N.A. (1993). Cloning and characterization of subunits of the T-cell receptor and murine leukemia virus enhancer core-binding factor. Mol. Cell. Biol. 13,3324\u20133339", "journal-title": "Biol"}], "container-title": ["Haematology and Blood Transfusion H\u00e4matologie und Bluttransfusion", "Acute Leukemias IX"], "link": [{"URL": "http://www.springerlink.com/index/pdf/10.1007/978-3-642-59358-1_8", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 4, 24]], "date-time": "2019-04-24T00:02:19Z", "timestamp": 1556064139000}, "score": 41.649563, "issued": {"date-parts": [[2003]]}, "ISBN": ["9783642639494", "9783642593581"], "references-count": 20, "URL": "http://dx.doi.org/10.1007/978-3-642-59358-1_8", "relation": {"cites": []}, "ISSN": ["0440-0607"], "issn-type": [{"value": "0440-0607", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 12, 5]], "date-time": "2019-12-05T07:15:56Z", "timestamp": 1575530156313}, "reference-count": 0, "publisher": "American Society of Hematology", "issue": "5", "content-domain": {"domain": ["ashpublications.org"], "crossmark-restriction": true}, "published-print": {"date-parts": [[1990, 3, 1]]}, "abstract": "<jats:p>In the majority of Philadelphia (Ph)-positive chronic myeloid leukemia (CML) patients, the c-abl gene is fused to the bcr gene, resulting in the transcription of an 8.5 kb chimeric bcr-abl mRNA, which is translated into a p210bcr-abl fusion protein. In about 50% of the Ph- positive acute lymphoid leukemias (ALL), the bcr-abl gene fusion is identical to CML, while in 50% an alternative fusion between these two genes occurs, in which the central bcr-sequences are absent. This results in transcription of a 7 kb bcr-abl mRNA, encoding a P190bcr-abl fusion protein. Cloning and sequencing of the chimeric part of bcr-abl cDNAs from two Ph-positive CML patients in chronic phase showed that in one patient, as in the Ph-positive ALL, all central bcr sequences are absent, while in the other patient, part of the bcr central sequences are deleted. Therefore, we speculate that the presence of the 7 kb chimeric ALL type mRNA in one of the patients is not sufficient to drive an acute rather than a chronic leukemic process in this case. The deletions of the central bcr-sequences described here define the minimal sequence requirement of the bcr-abl fusion gene in CML patients so far.</jats:p>", "DOI": "10.1182/blood.v75.5.1146.bloodjournal7551146", "type": "journal-article", "created": {"date-parts": [[2019, 10, 12]], "date-time": "2019-10-12T23:01:26Z", "timestamp": 1570921286000}, "page": "1146-1153", "update-policy": "http://dx.doi.org/10.1182/blood.2019cm0000", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Chronic myeloid leukemia may be associated with several bcr-abl transcripts including the acute lymphoid leukemia-type 7 kb transcript [see comments]"], "prefix": "10.1182", "volume": "75", "author": [{"given": "L", "family": "Selleri", "sequence": "first", "affiliation": [{"name": "Department of Cell Biology and Genetics, Erasmus University, Rotterdam, The Netherlands."}]}, {"given": "M", "family": "von Lindern", "sequence": "additional", "affiliation": [{"name": "Department of Cell Biology and Genetics, Erasmus University, Rotterdam, The Netherlands."}]}, {"given": "A", "family": "Hermans", "sequence": "additional", "affiliation": [{"name": "Department of Cell Biology and Genetics, Erasmus University, Rotterdam, The Netherlands."}]}, {"given": "D", "family": "Meijer", "sequence": "additional", "affiliation": [{"name": "Department of Cell Biology and Genetics, Erasmus University, Rotterdam, The Netherlands."}]}, {"given": "G", "family": "Torelli", "sequence": "additional", "affiliation": [{"name": "Department of Cell Biology and Genetics, Erasmus University, Rotterdam, The Netherlands."}]}, {"given": "G", "family": "Grosveld", "sequence": "additional", "affiliation": [{"name": "Department of Cell Biology and Genetics, Erasmus University, Rotterdam, The Netherlands."}]}], "member": "234", "container-title": ["Blood"], "language": "en", "link": [{"URL": "http://ashpublications.org/blood/article-pdf/75/5/1146/217241/1146.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "syndication"}, {"URL": "http://ashpublications.org/blood/article-pdf/75/5/1146/217241/1146.pdf", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 11, 20]], "date-time": "2019-11-20T02:25:40Z", "timestamp": 1574216740000}, "score": 41.472347, "issued": {"date-parts": [[1990, 3, 1]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[1990, 3, 1]]}, "issue": "5"}, "URL": "http://dx.doi.org/10.1182/blood.v75.5.1146.bloodjournal7551146", "ISSN": ["0006-4971", "1528-0020"], "issn-type": [{"value": "0006-4971", "type": "print"}, {"value": "1528-0020", "type": "electronic"}], "subject": ["Immunology", "Cell Biology", "Biochemistry", "Hematology"]}, {"indexed": {"date-parts": [[2019, 12, 5]], "date-time": "2019-12-05T07:24:37Z", "timestamp": 1575530677239}, "reference-count": 0, "publisher": "American Society of Hematology", "issue": "5", "content-domain": {"domain": ["ashpublications.org"], "crossmark-restriction": true}, "published-print": {"date-parts": [[1990, 3, 1]]}, "abstract": "<jats:title>Abstract</jats:title>\n               <jats:p>In the majority of Philadelphia (Ph)-positive chronic myeloid leukemia (CML) patients, the c-abl gene is fused to the bcr gene, resulting in the transcription of an 8.5 kb chimeric bcr-abl mRNA, which is translated into a p210bcr-abl fusion protein. In about 50% of the Ph- positive acute lymphoid leukemias (ALL), the bcr-abl gene fusion is identical to CML, while in 50% an alternative fusion between these two genes occurs, in which the central bcr-sequences are absent. This results in transcription of a 7 kb bcr-abl mRNA, encoding a P190bcr-abl fusion protein. Cloning and sequencing of the chimeric part of bcr-abl cDNAs from two Ph-positive CML patients in chronic phase showed that in one patient, as in the Ph-positive ALL, all central bcr sequences are absent, while in the other patient, part of the bcr central sequences are deleted. Therefore, we speculate that the presence of the 7 kb chimeric ALL type mRNA in one of the patients is not sufficient to drive an acute rather than a chronic leukemic process in this case. The deletions of the central bcr-sequences described here define the minimal sequence requirement of the bcr-abl fusion gene in CML patients so far.</jats:p>", "DOI": "10.1182/blood.v75.5.1146.1146", "type": "journal-article", "created": {"date-parts": [[2019, 10, 13]], "date-time": "2019-10-13T19:19:30Z", "timestamp": 1570994370000}, "page": "1146-1153", "update-policy": "http://dx.doi.org/10.1182/blood.2019cm0000", "source": "Crossref", "is-referenced-by-count": 2, "title": ["Chronic myeloid leukemia may be associated with several bcr-abl transcripts including the acute lymphoid leukemia-type 7 kb transcript [see comments]"], "prefix": "10.1182", "volume": "75", "author": [{"given": "L", "family": "Selleri", "sequence": "first", "affiliation": [{"name": "Department of Cell Biology and Genetics, Erasmus University, Rotterdam, The Netherlands."}]}, {"given": "M", "family": "von Lindern", "sequence": "additional", "affiliation": [{"name": "Department of Cell Biology and Genetics, Erasmus University, Rotterdam, The Netherlands."}]}, {"given": "A", "family": "Hermans", "sequence": "additional", "affiliation": [{"name": "Department of Cell Biology and Genetics, Erasmus University, Rotterdam, The Netherlands."}]}, {"given": "D", "family": "Meijer", "sequence": "additional", "affiliation": [{"name": "Department of Cell Biology and Genetics, Erasmus University, Rotterdam, The Netherlands."}]}, {"given": "G", "family": "Torelli", "sequence": "additional", "affiliation": [{"name": "Department of Cell Biology and Genetics, Erasmus University, Rotterdam, The Netherlands."}]}, {"given": "G", "family": "Grosveld", "sequence": "additional", "affiliation": [{"name": "Department of Cell Biology and Genetics, Erasmus University, Rotterdam, The Netherlands."}]}], "member": "234", "container-title": ["Blood"], "language": "en", "link": [{"URL": "http://ashpublications.org/blood/article-pdf/75/5/1146/602835/1146.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "syndication"}, {"URL": "http://ashpublications.org/blood/article-pdf/75/5/1146/602835/1146.pdf", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 11, 20]], "date-time": "2019-11-20T02:43:29Z", "timestamp": 1574217809000}, "score": 41.472347, "issued": {"date-parts": [[1990, 3, 1]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[1990, 3, 1]]}, "issue": "5"}, "URL": "http://dx.doi.org/10.1182/blood.v75.5.1146.1146", "ISSN": ["0006-4971", "1528-0020"], "issn-type": [{"value": "0006-4971", "type": "print"}, {"value": "1528-0020", "type": "electronic"}], "subject": ["Immunology", "Cell Biology", "Biochemistry", "Hematology"]}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T19:49:52Z", "timestamp": 1574538592286}, "reference-count": 33, "publisher": "Elsevier BV", "issue": "1", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2015, 1, 1]], "date-time": "2015-01-01T00:00:00Z", "timestamp": 1420070400000}, "delay-in-days": 0, "content-version": "tdm"}, {"URL": "http://creativecommons.org/licenses/by-nc-nd/3.0/", "start": {"date-parts": [[2014, 7, 29]], "date-time": "2014-07-29T00:00:00Z", "timestamp": 1406592000000}, "delay-in-days": 0, "content-version": "vor"}], "funder": [{"DOI": "10.13039/501100001659", "name": "German Research Foundation", "doi-asserted-by": "crossref", "award": ["KA 2799/1"]}, {"name": "Leukaemia & Lymphoma NI", "award": ["R2561CNR"]}, {"name": "START-Program of the Faculty of Medicine, RWTH Aachen University", "award": []}], "content-domain": {"domain": ["elsevier.com", "sciencedirect.com"], "crossmark-restriction": true}, "short-container-title": ["Blood Cells, Molecules, and Diseases"], "published-print": {"date-parts": [[2015, 1]]}, "DOI": "10.1016/j.bcmd.2014.07.009", "type": "journal-article", "created": {"date-parts": [[2014, 8, 12]], "date-time": "2014-08-12T20:04:09Z", "timestamp": 1407873849000}, "page": "123-131", "update-policy": "http://dx.doi.org/10.1016/elsevier_cm_policy", "source": "Crossref", "is-referenced-by-count": 9, "title": ["DEK oncogene expression during normal hematopoiesis and in Acute Myeloid Leukemia (AML)"], "prefix": "10.1016", "volume": "54", "author": [{"given": "Gemma E.", "family": "Logan", "sequence": "first", "affiliation": []}, {"given": "Nirit", "family": "Mor-Vaknin", "sequence": "additional", "affiliation": []}, {"given": "Till", "family": "Braunschweig", "sequence": "additional", "affiliation": []}, {"given": "Edgar", "family": "Jost", "sequence": "additional", "affiliation": []}, {"given": "Pia Verena", "family": "Schmidt", "sequence": "additional", "affiliation": []}, {"given": "David M.", "family": "Markovitz", "sequence": "additional", "affiliation": []}, {"given": "Ken I.", "family": "Mills", "sequence": "additional", "affiliation": []}, {"given": "Ferdinand", "family": "Kappes", "sequence": "additional", "affiliation": []}, {"given": "Melanie J.", "family": "Percy", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Blood Cells, Molecules, and Diseases"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S1079979614000886?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S1079979614000886?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2018, 10, 1]], "date-time": "2018-10-01T00:56:54Z", "timestamp": 1538355414000}, "score": 40.35846, "issued": {"date-parts": [[2015, 1]]}, "references-count": 33, "journal-issue": {"published-print": {"date-parts": [[2015, 1]]}, "issue": "1"}, "alternative-id": ["S1079979614000886"], "URL": "http://dx.doi.org/10.1016/j.bcmd.2014.07.009", "ISSN": ["1079-9796"], "issn-type": [{"value": "1079-9796", "type": "print"}], "assertion": [{"value": "Elsevier", "name": "publisher", "label": "This article is maintained by"}, {"value": "DEK oncogene expression during normal hematopoiesis and in Acute Myeloid Leukemia (AML)", "name": "articletitle", "label": "Article Title"}, {"value": "Blood Cells, Molecules, and Diseases", "name": "journaltitle", "label": "Journal Title"}, {"value": "https://doi.org/10.1016/j.bcmd.2014.07.009", "name": "articlelink", "label": "CrossRef DOI link to publisher maintained version"}, {"value": "article", "name": "content_type", "label": "Content Type"}, {"value": "Copyright \u00a9 2014 The Authors. Published by Elsevier Inc.", "name": "copyright", "label": "Copyright"}]}, {"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T10:38:46Z", "timestamp": 1574159926785}, "reference-count": 0, "publisher": "Wiley", "issue": "2", "license": [{"URL": "http://doi.wiley.com/10.1002/tdm_license_1.1", "start": {"date-parts": [[2015, 9, 1]], "date-time": "2015-09-01T00:00:00Z", "timestamp": 1441065600000}, "delay-in-days": 4475, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Genes Chromosom. Cancer"], "published-print": {"date-parts": [[2003, 6]]}, "DOI": "10.1002/gcc.10198", "type": "journal-article", "created": {"date-parts": [[2003, 4, 10]], "date-time": "2003-04-10T10:01:40Z", "timestamp": 1049968900000}, "page": "149-158", "source": "Crossref", "is-referenced-by-count": 93, "title": ["Genome-wide analysis of acute myeloid leukemia with normal karyotype reveals a unique pattern of homeobox gene expression distinct from those with translocation-mediated fusion events"], "prefix": "10.1002", "volume": "37", "author": [{"given": "Silvana", "family": "Debernardi", "sequence": "first", "affiliation": []}, {"given": "Debra M.", "family": "Lillington", "sequence": "additional", "affiliation": []}, {"given": "Tracy", "family": "Chaplin", "sequence": "additional", "affiliation": []}, {"given": "Simon", "family": "Tomlinson", "sequence": "additional", "affiliation": []}, {"given": "John", "family": "Amess", "sequence": "additional", "affiliation": []}, {"given": "Ama", "family": "Rohatiner", "sequence": "additional", "affiliation": []}, {"given": "T. Andrew", "family": "Lister", "sequence": "additional", "affiliation": []}, {"given": "Bryan D.", "family": "Young", "sequence": "additional", "affiliation": []}], "member": "311", "container-title": ["Genes, Chromosomes and Cancer"], "link": [{"URL": "https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fgcc.10198", "content-type": "unspecified", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://onlinelibrary.wiley.com/doi/full/10.1002/gcc.10198", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2018, 7, 31]], "date-time": "2018-07-31T11:19:45Z", "timestamp": 1533035985000}, "score": 40.169495, "issued": {"date-parts": [[2003, 6]]}, "references-count": 0, "journal-issue": {"issue": "2"}, "URL": "http://dx.doi.org/10.1002/gcc.10198", "ISSN": ["1045-2257", "1098-2264"], "issn-type": [{"value": "1045-2257", "type": "print"}, {"value": "1098-2264", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 21]], "date-time": "2019-11-21T01:10:37Z", "timestamp": 1574298637514}, "reference-count": 0, "publisher": "Elsevier BV", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2009, 5, 1]], "date-time": "2009-05-01T00:00:00Z", "timestamp": 1241136000000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Leukemia Research"], "published-print": {"date-parts": [[2009, 5]]}, "DOI": "10.1016/s0145-2126(09)70056-6", "type": "journal-article", "created": {"date-parts": [[2009, 5, 4]], "date-time": "2009-05-04T08:39:08Z", "timestamp": 1241426348000}, "page": "S42-S43", "source": "Crossref", "is-referenced-by-count": 0, "title": ["C018 Unregulated expression of the orphan nuclear receptor NR2F6 in mice initiates myelodysplastic syndrome that can progress to acute leukemia"], "prefix": "10.1016", "volume": "33", "author": [{"given": "C.", "family": "Ichim", "sequence": "first", "affiliation": []}, {"given": "A.", "family": "Chesney", "sequence": "additional", "affiliation": []}, {"given": "M.", "family": "Reis", "sequence": "additional", "affiliation": []}, {"given": "R.", "family": "Wells", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Leukemia Research"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0145212609700566?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0145212609700566?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2018, 12, 20]], "date-time": "2018-12-20T05:58:25Z", "timestamp": 1545285505000}, "score": 39.932377, "issued": {"date-parts": [[2009, 5]]}, "references-count": 0, "alternative-id": ["S0145212609700566"], "URL": "http://dx.doi.org/10.1016/s0145-2126(09)70056-6", "ISSN": ["0145-2126"], "issn-type": [{"value": "0145-2126", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 26]], "date-time": "2019-11-26T01:55:03Z", "timestamp": 1574733303030}, "reference-count": 0, "publisher": "American Society for Microbiology", "issue": "8", "content-domain": {"domain": ["asm.org"], "crossmark-restriction": true}, "short-container-title": ["Mol. Cell. Biol."], "published-print": {"date-parts": [[1992, 8]]}, "abstract": "<jats:p>The translocation (6;9)(p23;q34) in acute nonlymphocytic leukemia results in the formation of a highly consistent dek-can fusion gene. Translocation breakpoints invariably occur in single introns of dek and can, which were named icb-6 and icb-9, respectively. In a case of acute undifferentiated leukemia, a breakpoint was detected in icb-9 of can, whereas no breakpoint could be detected in dek. Genomic and cDNA cloning showed that instead of dek, a different gene was fused to can, which was named set. set encodes transcripts of 2.0 and 2.7 kb that result from the use of alternative polyadenylation sites. Both transcripts contain the open reading frame for a putative SET protein with a predicted molecular mass of 32 kDa. The set-can fusion gene is transcribed into a 5-kb transcript that contains a single open reading frame predicting a 155-kDa chimeric SET-CAN protein. The SET sequence shows homology with the yeast nucleosome assembly protein NAP-I. The only common sequence motif of SET and DEK proteins is an acidic region. SET has a long acidic tail, of which a large part is present in the predicted SET-CAN fusion protein. The set gene is located on chromosome 9q34, centromeric of c-abl. Since a dek-can fusion gene is present in t(6;9) acute myeloid leukemia and a set-can fusion gene was found in a case of acute undifferentiated leukemia, we assume that can may function as an oncogene activated by fusion of its 3' part to dek, set, or perhaps other genes.</jats:p>", "DOI": "10.1128/mcb.12.8.3346", "type": "journal-article", "created": {"date-parts": [[2015, 10, 6]], "date-time": "2015-10-06T00:30:48Z", "timestamp": 1444091448000}, "page": "3346-3355", "update-policy": "http://dx.doi.org/10.1128/asmj-crossmark-policy-page", "source": "Crossref", "is-referenced-by-count": 250, "title": ["Can, a putative oncogene associated with myeloid leukemogenesis, may be activated by fusion of its 3' half to different genes: characterization of the set gene."], "prefix": "10.1128", "volume": "12", "author": [{"given": "M", "family": "von Lindern", "sequence": "first", "affiliation": []}, {"given": "S", "family": "van Baal", "sequence": "additional", "affiliation": []}, {"given": "J", "family": "Wiegant", "sequence": "additional", "affiliation": []}, {"given": "A", "family": "Raap", "sequence": "additional", "affiliation": []}, {"given": "A", "family": "Hagemeijer", "sequence": "additional", "affiliation": []}, {"given": "G", "family": "Grosveld", "sequence": "additional", "affiliation": []}], "member": "235", "published-online": {"date-parts": [[1992, 8, 1]]}, "container-title": ["Molecular and Cellular Biology"], "language": "en", "link": [{"URL": "https://syndication.highwire.org/content/doi/10.1128/MCB.12.8.3346", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2016, 12, 23]], "date-time": "2016-12-23T07:36:10Z", "timestamp": 1482478570000}, "score": 39.884415, "issued": {"date-parts": [[1992, 8]]}, "references-count": 0, "journal-issue": {"published-online": {"date-parts": [[1992, 8, 1]]}, "published-print": {"date-parts": [[1992, 8]]}, "issue": "8"}, "alternative-id": ["10.1128/MCB.12.8.3346"], "URL": "http://dx.doi.org/10.1128/mcb.12.8.3346", "ISSN": ["0270-7306", "1098-5549"], "issn-type": [{"value": "0270-7306", "type": "print"}, {"value": "1098-5549", "type": "electronic"}]}], "items-per-page": 20, "query": {"start-index": 0, "search-terms": null}}}